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CHAPTER I 
INTRODUCTION 
Biological rhythms are present throughout nature. Frequencies of 
these rhythms can range from several cycles per second to only a single cycle 
per year. Midway between these extremes are circadian (circa = around, dia = 
day) rhythms. These rhythms cycle over a 23 - 26 hour period and include the 
rhythms of sleep, locomotor activity, hormone secretion and body 
temperature. The time frame over which these rhythms repeats is genetically 
determined. They are maintained in the absence of external cues. 
Synchronization of these rhythms with the 24 hour light-dark cycle requires 
the input of an outside "zeitgeber" or "time giver". In mammals, the most 
powerful zeitgeber appears to be light. Information about changes in the 
light-dark cycle is conveyed directly from photoreceptors in the retina to an 
endogenous rhythm generator within the brain, the suprachiasmatic nucleus 
(SCN). From the SCN, photic information is processed into neuronal and 
hormonal signals that convey physiological information to the animal about 
the time of day or season. 
The pineal gland, via its secretion of the hormone melatonin, is an 
important component of the neuroendocrine system regulating the 
rhythmicity of an organism. The reception of light by the retina inhibits the 
synthesis of melatonin, via a multisynaptic pathway that includes the SCN. 
Synthesized from the amino acid tryptophan, melatonin has been suggested 
to play a role in such diverse phenomena as the regulation of body 
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temperature (Morton 1987), thyroid gland function (Vriend et al. 1977), and 
pigmentation (Bagnara and Hadley 1970). One of the most extensively 
studied functions of the pineal gland is its interaction with the hypothalamic-
pituitary-reproductive axis (Reiter 1980). More recently, several studies in 
humans have suggested possible roles for melatonin in chronobiological and 
psychobiological functions (Lowry et al. 1985; Vaughan 1984). 
Neural regulation of melatonin synthesis has been well characterized. 
At the onset of darkness, norepinephrine (NE) is released from nerve 
terminals within the pineal gland and stimulates, via a.- and p-adrenergic 
receptors on pinealocytes, the N-acetylation of serotonin (derived from the 
amino acid tryptophan). The product of this reaction, N-acetylserotonin, is 
methylated to form melatonin, which is then released into the general 
circulation. 
The idea that melatonin synthesis can be modulated by 
neurotransmitters or circulating factors other than NE has recently gained 
attention. One potential modulator, the amino acid glutamate, is an 
important excitatory neurotransmitter within the central nervous system 
(Mayer and Westbrook 1987). The recent report that glutamate is the 
dominant excitatory neurotransmitter within the neuroendocrine 
hypothalamus also suggests the possibility that this amino acid may play an 
important role in other neuroendocrine systems (Van den Pol et al. 1990). 
The present study is based on the observation that the pineal gland 
possesses high levels of free glutamate and a number of "orphan" receptors 
whose role in melatonin synthesis are unknown. The experiments in this 
study were designed to test the hypothesis that glutamate plays a 
neuromodulatory role in pineal gland function in the rat. Based on the fact 
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that the NE content of the pineal gland exhibits a distinct circadian rhythm 
(Craft et al. 1984), the first series of experiments examined amino acid content 
of the pineal gland over the 24 hour light-dark cycle. The effect of 
sympathetic denervation on amino acid content was also examined, as 
several pineal gland rhythms, e.g. serotonin and melatonin content, are 
known to be synchronized by the rhythmic release of NE from neurons of the 
SCG. While glutamate has been previously demonstrated to inhibit the NE-
stimulated activation of the rate limiting enzyme in the synthesis of 
melatonin in the rat in vitro (Govitrapong and Ebadi 1988), a source of 
"transmitter" glutamate for the gland has not been demonstrated. To 
determine if glutamate was concentrated in nerve terminals, 
semiquantitative immunocytochemistry was employed. 
The second series of experiments established the presence of 
[3H]glutamate binding sites in the pineal gland of the rat. Not previously 
demonstrated in the pineal gland of this species, [3H]glutamate binding site 
number, affinity, and subtype were assessed with the use of in vitro receptor 
autoradiography. The hypothesis that maintenance of glutamate binding site 
number and affinity is dependent on an intact sympathetic innervation was 
tested by examining [3H]glutamate binding after superior cervical 
ganglionectomy (SCGx). [3H]Glutamate binding was also examined in pineal 
glands obtained from animals sacrificed during the middle of the light and 
dark periods. 
A third series of experiments tested the hypothesis that glutamate 
modulates pineal gland indole metabolism. The effect of glutamate and its 
analogues on the adrenergic-stimulated secretion of melatonin in vitro was 
examined. 
CHAPTER II 
REVIEW OF THE LITERATURE 
The pineal organ is present in almost all vertebrate species. As 
demonstrated by the fossil record, the pineal organ is an ancient structure, 
believed to have been present in certain tetrapods of the Devonian and 
Silurian periods (Oksche 1965). During evolution, there are few organs in the 
body that have undergone as much change morphologically and functionally 
as the pineal organ. The pineal organ of lower vertebrates, e.g. lamprey, fish, 
and amphibians, consists of cone-like photoreceptors that synapse onto 
second order neurons, whose axons project to various brain areas (Collin and 
Oksche 1981). Pineal photoreceptors, like retinal photoreceptors, possess an 
outer and inner segment, cell soma, and synaptic terminal. Pineal 
photoreceptors possess many of the same cellular markers found in retinal 
photoreceptors. Molecules found in both retinal and pineal photoreceptors 
include opsin, a-transducin, S-antigen, and various photolabile pigments 
(Collin et al. 1986; Oksche and Hartwig 1979). Cellular organelles specific to 
the retinal photoreceptor such as the 9 X 2 + 0 cilium located in the outer 
segment and synaptic ribbons located in the synaptic pedicle are also present 
in pineal photoreceptors (McNulty 1984). In the retina, communication 
between photoreceptors and secondary neurons is mediated by excitatory 
amino acids released from the photoreceptor synaptic pedicle (Copenhagen 
and Jahr 1989). These amino acids bind to glutamate receptors of the 2-
4 
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amino-4-phosphonobutyric acid (APB) subtype located on secondary neurons 
(bipolar and horizontal cells) (Muller et al. 1988; Slaughter and Miller 1981). 
The presence of autoreceptors for excitatory amino acid on photoreceptors is 
also suggested by physiological studies that demonstrate the ability of 
glutamate to depolarize photoreceptors (Sarantis et al. 1988; Tachibana and 
Kaneko 1988). 
In reptiles and birds, the typical photoreceptor becomes modified 
(Collin and Oksche 1981). The most obvious changes are seen in the outer 
segment where there is a decrease in the number of disks present and in the 
synaptic pedicle where there is a disconnection from, and disappearance of, 
second order neurons. While it is not clear whether all modified 
photoreceptors can detect light directly, information about the light/ dark cycle 
can be relayed to the photoreceptor indirectly via pathways originating in the 
retina (Kappers 1965). 
In mammals and snakes, the modified photoreceptor has been almost 
completely replaced by the secretory pinealocyte (Collin et al. 1986). The 
pineal organ in these species consists primarily of two cell types, glial cells and 
chief cells (pinealocytes). Chief cells, while retaining many of the cellular 
markers found in photoreceptors, e.g. opsin (Korf et al. 1985), S-antigen (Korf 
et al. 1985), and a-transducin (Van Veen et al. 1986), are mainly involved in 
indole metabolism (Reiter 1991). Cilia of the 9 X 2 + 0 variety (Karasek 1983) 
and synaptic ribbons (McNulty et al. 1987) are also present in the secretory 
pinealocyte. The pineal organ of mammals no longer possesses any direct 
photoreceptive capacity but receives information about changes in the 
light/ dark cycle via a multisynaptic pathway originating in the retina (Moore 
1978). 
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Peripheral Innervation of the Mammalian Pineal Gland 
Information about changes in the light/dark cycle reaches the 
mammalian pineal gland via a neural pathway originating in the retina 
(Moore et al. 1964) (Fig. 1). Ganglion cells within the retina send 
unmyelinated fibers to the suprachiasmatic nuclei (SCN) of the 
hypothalamus via the optic nerve (Moore 1973). Most of the fibers in this 
tract, referred to as the retinohypothalamic tract, cross before terminating in 
the contralateral SCN (Moore and Lenn 1972). While it is known that 
lesioning the SCN results in the loss of the cyclic production of the pineal 
hormone melatonin (Moore and Klein 1974), the pathways that connect the 
SCN to the pineal gland have not been fully defined. One possible route may 
involve SCN projections to the paraventricular nucleus (PVN) of the 
hypothalamus (Silverman et al. 1981). Lesions of the PVN have been shown 
to disrupt the melatonin generating capacity of the pineal gland (Klein et al. 
1983). While a direct projection from the PVN to the deep pineal (= pineal 
tissue present within the dorsal posterior diencephalon) has been reported 
(Reuss and Moller 1986), neurons in the PVN also have direct projections to 
the preganglionic sympathetic neurons in the intermediolateral cell column 
of the spinal cord (Swanson and Kuypers 1980). Axons from these 
preganglionic neurons, which are located primarily in spinal cord levels Tl -
T3 (Gilbey et al. 1982), leave the spinal cord via the ventral roots and travel to 
the superior cervical ganglion (SCG) where they synapse with postganglionic 
sympathetic neurons (Rando et al. 1981). Projections from the SCG enter into 
the brain by traveling with branches of the internal carotid artery (Hedger and 
Webber 1976). Fibers destined for the pineal gland pass through the 
tentorium cerebelli and reform as one or two nerves referred to as the nervi 
conarii (Kappers 1964). These nerves enter the pineal gland at its apex and 
terminate in the pericapillary space (Kappers 1960) where they release the 
neurotransmitter NE. 
Fig. 1 
Light ---•• Retina ---•• Suprachiasmatic ---•• Paraventricular 
Nucleus Nucleus 
Pineal Gland ... •a--
~ 
Spinal Cord 
Superior Cervical 
Ganglia 
Central Innervation of the Pineal Gland in the Rat 
While the sympathetic innervation of the rat pineal gland has been 
extensively studied, knowledge of pinealopetal projections is limited. The 
observation that all or most nerve terminals in the gland disappeared after 
removal of the SCG led earlier investigators to believe that the gland was 
innervated exclusively by the sympathetic nervous system (Kappers 1960). 
More recent anatomical and electrophysiological studies, however, have 
suggested that various brain regions project directly to the pineal gland via 
the pineal stalk. Injection of the neuronal tracer horseradish peroxidase 
(HRP) into the superficial portion of the pineal gland produced labeled fibers 
and neurons within the habenular complex (Dafny 1983), while lesioning of 
the medial habenular nuclei resulted in the appearance of degenerating fibers 
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and terminals within the pineal gland (Ronnekleiv and Moller 1979). When 
HRP was used as an anterograde tracer and injected into the PVN, labeled 
fibers were found in the deep pineal and the pineal stalk (Reuss and Moller 
1986). Injection of the more sensitive anterograde tracer Phaseolus 
leucoagglutinin into the intergeniculate leaflett of the lateral geniculate 
nucleus (Mikkelsen and Moller 1990) or the anterior and tuberal regions of 
the hypothalamus (Fink-Jensen and Moller 1990) also produced labeled nerve 
fibers that terminated in the deep pineal and pineal stalk. 
Further evidence for the existence of central pineal connections has 
been obtained from electrophysiological studies. In a study by Martin and 
Meissl (1990), extracellular potentials evoked by brief photic stimulation of 
the eyes were recorded from single cells in the pineal gland before and after 
removal of the SCG. Removal of the sympathetic innervation did not 
impede evoked extracellular potentials, suggesting that light information can 
reach the pineal gland via central connections. Evoked potentials were also 
recorded in the pineal gland after electrical stimulation of the habenula 
(Ronnekleiv et al. 1980). 
Although there appears to be considerable evidence in support of a 
central innervation of the pineal gland, not all studies agree. Patrickson and 
Smith (1987) noted, for example, that after careful injection of HRP into the 
pineal gland labeled neurons could be found only within the SCG. It was 
noted by these authors that "the encapsulation and lack of rigid attachment of 
the pineal make it very difficult to penetrate" (Patrickson and Smith 1987). 
They found that even when the pineal gland was surgically exposed and 
carefully injected, tracer sometimes leaked from the site of entry. In cases 
where tracer was found to leak, neurons in various brain areas were found to 
contain the HRP label (Patrickson and Smith 1987). A similar pattern of 
labeling was observed by Stanley et al. (1987) after pineal glands were injected 
with the neuronal tracers HRP, wheat germ agglutinin-HRP conjugate, fast 
blue, and rhodamine microspheres. Additionally, the observation that some 
sympathetic fibers from the SCG project into the medial habenular nuclei 
after passing through the pineal gland (Patrickson and Smith 1987) suggests 
that the degenerating nerve terminals found in the pineal gland after 
lesioning the habenular nuclei (Ronnekleiv and Moller 1979) may not be 
pinealopetal projections but simply retrogradely degenerating sympathetic 
fibers. Likewise, the evoked potentials noted in the pineal gland after 
stimulation of the habenula (Ronnekleiv et al. 1980) could be the result of 
antidromic conduction along sympathetic fibers. 
Biochemistry of Melatonin Synthesis 
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The pineal hormone melatonin is synthesized from the amino acid 
tryptophan via a multienzymatic pathway. Tryptophan, found in low 
concentrations within the pineal gland, is actively taken up from the 
circulation and converted to 5-hydroxytryptophan by the mitochondrial 
enzyme tryptophan hydroxylase (TPH) (Fig. 2) (Klein et al. 1981; Sugden 1979). 
The activity of TPH is reported in rats to increase at night with peak activity 
occuring 7 hours after lights out (Sitaram and Lees 1978). 5-
Hydroxytryptophan is subsequently oxidized to 5-hydroxytryptamine (SHT or 
serotonin) by the cytoplasmic enzyme L-amino acid decarboxylase (L-AAD) 
(Fig. 2). While the substrate specificity of this enzyme is low, the activity of L-
AAD is reported to be higher in the pineal than in any other tissue examined 
(Klein et al. 1981). Changes in L-AAD enzyme activity over the light-dark 
cycle have not been reported. 
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Relative to other brain areas the pineal gland possesses high 
concentrations of SHT (King et al. 1984; Quay 1963). The levels of this indole 
vary over the light-dark cycle with concentrations being highest during the 
light period and lowest at night (Quay 1963; Snyder et al. 1967). If the light-
dark cycle is reversed and the animal is allowed to acclimate, the production 
of SHT will likewise be reversed (Snyder et al. 1967). Because these rhythms 
are endogenously generated, animals kept in constant darkness will have a 
persistent SHT rhythm that will cycle approximately once every 24 hours. 
Animals kept in constant light, on the other hand, display no rhythm in SHT 
production, demonstrating the inhibitory nature of light on this rhythm 
generator (Snyder et al. 1965). 
In addition to its role as a melatonin precursor, SHT can be processed 
via several different pathways within the pineal gland (Fig. 3). It can be 
released unchanged into the general circulation or CSF (Aloyo and Walker 
1988). It can be methylated to form 5-methoxytryptamine, a putative pineal 
hormone (Pevet 1983). It can be converted by the mitochondrial enzyme 
monoamine oxidase (MAO) into the unstable 5-hydroxyindole acetaldehyde, 
which is subsequently converted to either 5-hydroxy indole acetic acid 
(SHIAA) by the enzyme aldehydehydrogenase or to 5-hydroxytrptophol by the 
enzyme alcohol dehydrogenase (Klein et al. 1981). 
N-acetylation of SHT by serotonin N-acetyltransferase (SNAT), the rate 
limiting enzyme in the synthesis of melatonin, produces N-acetylserotonin 
(NAS) (Fig. 2). While there are two known types of N-acetyltransferase 
enzymes within the pineal, the enzyme responsible for the production of 
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NAS is highly specific for arylalkylamines (aromatic compounds that possess 
a side chain with a primary ring) (Voisin et al. 1984). For this reason it is 
often referred to as arylalkylamine N-acetyltransferase, or more commonly, 
serotonin N-acetyltransferase (SNAT). A 24 hour rhythm in the activity of 
SNAT has been demonstrated with a 20-100 fold increase in enzyme activity 
during the night (Klein and Weller 1970). A full melatonin response can be 
achieved with only a 10% activation of SNAT (Wheler et al. 1979). The 
enzymatic conversion of SHT to NAS is the rate limiting step in the 
production of melatonin. 
The conversion of NAS to N-acetyl 5-methoxytryptamine (melatonin) 
is catalyzed by the cytosolic enzyme hydroxyindole 0-methyltransferase 
(HIOMT) (Fig. 2). Found in high concentrations in the pineal gland, HIOMT 
makes up approximately 4% of the total soluble proteins (Jackson and 
Lovenberg 1971). Although one early study reported no day-night variations 
in HIOMT activity (Axelrod et al. 1965), this finding has not been 
substantiated by other studies. Melatonin is released from the pineal gland at 
night in a pulsatile fashion, with pulses occuring at the rate of 2 - 4 per hour 
in the rat (Pang and Yip 1988). 
Fig. 2 
tryptophan hydroxylase 
Tryptophan _. 5-Hydroxytryptophan 
L-amino acid decarboxylase 
5-Hydroxytryptophan _. Serotonin (SHT) 
N-acety I transferase 
Serotonin (SHT) _. N-acetylserotonin 
hydroxyindole-O-methyltransferase 
N-acetylserotonin _. Melatonin 
Fig. 3 
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Adrenergic Stimulation of Melatonin Production 
Axelrod et al. (1969) first demonstrated the ability of NE to stimulate 
melatonin synthesis in the rat pineal gland in vitro. It was soon shown that 
the addition of the f3-adrenergic antagonist, propranolol, to NE-stimulated 
glands prevented the expected increase in melatonin production. The 
addition of the a-adrenergic antagonist, phenoxybenzamine, did not inhibit 
melatonin production. It was assumed from these studies that NE exerted its 
effects exclusively via the f3-adrenergic receptor (Wurtman et al. 1971). It was 
later shown, however, that activation of the al-receptors by NE plays a role in 
potentiating the f3-adrenergic induced response (Sugden et al. 1984). 
il-Adrenergic Receptor Activation in the Rat Pineal Gland 
f3-Adrenergic receptors have been characterized on rat pinealocyte 
membranes using a variety of ligands including [3H]alprenolol (Kebabian et 
al. 1975) and [3H]dihydroalprenolol (Cantor et al. 1981). More recent studies, 
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which have used the ~-adrenergic ligand, [125I]iodocyanopindolol, have 
identified a receptor with an apparent affinity (Kct) = 170 + 30 pM and a Bmax = 
548 + 13 fmol/mg protein (Craft et al. 1985). The binding of NE to~-
adrenergic receptors initiates the interaction of the receptor with a 
stimulatory guanine nucleotide protein (Gs) composed of three peptide 
chains, a,~' y. The a subunit of the Gs molecule binds GTP and uncouples 
from the G~ and Gy chains to activate adenylate cyclase, a membrane bound 
enzyme responsible for the conversion of ATP to cyclic AMP (cAMP). 
Activation of the ~-adrenergic receptor alone leads to approximately a 10 fold 
increase in the cAMP content in the gland (Vanecek et al. 1985). 
While peak levels of cAMP are reached within 10 minutes after 
adrenergic stimulation and decline thereafter, levels remain elevated over 
baseline throughout the dark period (Klein et al. 1978). Similarly, the activity 
of phosphodiesterase, the enzyme responsible for degrading cAMP, is found 
to be high throughout the dark phase (Minneman and Iverson 1976). In the 
rat, SNAT activation with subsequent melatonin production occurs 
approximately 1 - 2 hours after ~-adrenergic receptor stimulation (Klein et al. 
1983; Simonneaux et al. 1989). This increase in SNAT activity can be blocked 
by the administration of actinomycin D (an agent that binds DNA) as well as 
cycloheximide (a peptidyltransferase inhibitor), suggesting that both 
transcription and translation are necessary for the activation of this enzyme 
(Romero et al. 1975). Activation of the pinealocyte ~-adrenergic receptor also 
stimulates the production of cGMP 2 - 4 fold (Vanecek et al. 1985). The role of 
cGMP in pineal gland indole metabolism is unknown (Sugden 1989). 
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,a_-Adrenergic Receptor Activation in the Rat Pineal Gland 
The ability of a-adrenergic agonists to mimic the NE-induced 
stimulation of phospholipid metabolism was the first suggestion that a-
adrenergic receptors were present on the rat pineal gland. (Hauser et al. 1974). 
The receptor was later defined pharmacologically using the ligand 
[3H]dihydroergocryptine (Vacas et al. 1980) and shown to activate 
phosphatidylinositol metabolism via a postsynaptic mechanism (Smith et al. 
1979). al-Adrenergic receptors have been subsequently characterized with the 
use of the specific ligand [12SI]-2-[~-(4-hydroxyphenyl)-ethylaminomethyl]-
tetralone ([125I]HEAT) and found to possess a Kd = 48 + pM and Bmax = 341.6 
+ 126.4 fmol/mg protein (Sugden and Klein 1985). An approximate 1:2 ratio 
of a to ~ receptors has been reported in the rat pineal gland (Dickinson et al. 
1986). 
Noradrenergic stimulation of the pineal gland leads to the activation of 
the membrane bound enzyme phospholipase C (Ho et al. 1988). Based on the 
observation that the NE-stimulated production of inositol monophosphates 
is inhibited by the addition of al-adrenergic antagonists in vitro, it is 
postulated that the activity of this enzyme is controlled by the al-adrenergic 
receptor. In many cell types, phospholipase C cleaves inositol-containing 
membrane phospholipids to produce the second messengers inositol 1,4,5 
triphosphate (IP3) and diacylglycerol (DAG). IP3 production causes the release 
of Ca2+ from internal cellular stores while DAG stimulates the translocation 
of protein kinase C (PKC) from the cytosol to the cell membrane where it is 
activated. In the pineal gland little, if any, IP3 is formed in response to NE 
stimulation (Sugden et al. 1988; Sugden et al. 1987). Conversely, the activity 
of PKC in pinealocytes is high (Sugden 1991). While DAG is known to 
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activate PKC in many cell types, there is some question as to whether DAG 
activates PKC in the pinealocyte. It has been shown, for example, that . 
maximal PKC activity can be detected in pinealocytes three minutes after 
stimulation without any prior or concurrent increase in DAG. The isoforms 
of PKC present in the pineal gland are of the ex (80%) and p (20%) variety 
(Yoshida et al. 1988). 
In addition to the stimulation of phospholipase C, activation of the cxl-
adrenergic receptor leads to an influx of Ca2+ into the pinealocyte (Sugden et 
al. 1987). Intracellular levels of Ca2+ increase from a basal level of 100nM to 
approximately 350 nM in one minute and remain high for about 30 minutes 
after stimulation (Sugden, et al. 1987). The inability of nifedipine (a Ca2+ 
channel blocker) to inhibit this increase suggests that Ca2+ is not entering the 
cells via the well know voltage-sensitive Ca2+ channel present on 
pinealocytes (Sakai and Marks 1972). While an increase in intracellular Ca2+ 
appears to be necessary (and perhaps solely responsible) for the translocation 
and activation of PKC (Ho et al. 1988), the addition of Ca2+ ionophores by 
themselves are not sufficient to activate phospholipase C. 
PKC has been reported to have a negative feedback effect on the 
activation of the cxl-adrenergic receptor. A one minute pretreatment of 
pinealocytes with phorbol myristate acetate (PMA) (an activator of PKC) 
before the administration of NE reduced the cxl-adrenergic induced increase 
in intracellular Ca2+ by 50 % (Sugden et al. 1988). Likewise, pretreatment with 
PMA inhibited the ability of NE to stimulate the production of inositol 
monophosphate (Sugden et al. 1988). These authors have suggested that 
activation of the cxl-adrenergic receptor leads to an incease in intracellular 
Ca2+ which causes the translocation of PKC which inhibits the further 
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increase in intracellular Ca2+. It is believed that PKC phosphorylates and 
desensitizes tha al-adrenergic receptor to further stimulation (Leep-Lundberg 
et al. 1986). 
Additionally, a role for arachidonic acid metabolites in pineal gland 
function has been suggested by the observation that lipoxygenase inhibitors 
decrease NE-stimulated melatonin production while the products of this 
enzyme, 12- and 15-hydroxyperoxy-6,8,11,14-eicosatetraenoic acid (HPETE), 
increase melatonin production (See Fig. 4) (Sakai et al. 1988). Based on the 
Fig. 4 
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observation that activation of the pinealocyte al-adrenergic receptor, as well 
as administration of Ca2+ ionophores and phorbol esters to pinealocytes 
stimulates the release of arachidonic add, it has been suggested that the al-
adrenergic receptor mediates arachidonic acid metabolism. It has also been 
shown that activation of the al-adrenergic receptor or direct activation of 
PKC by phorbol esters causes an increase in intracellular pH (Ho et al. 1989). 
,a-Adrenergic Potentiation of 13-Adrenergic Stimulated 
cAMP and cGMP Production 
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Stimulation of the cx1-adrenergic receptor by itself does not increase 
cyclic nucleotide production (Vanecek et al. 1985). Activation of this receptor 
does, however, potentiate the ~-adrenergic induced production of cAMP and 
cGMP in pinealocytes 60 to 100 fold (Sugden 1990; Vanecek et al. 1985). Based 
on the observation that synthetic activators of PKC, e.g. phorbol 12-myristate, 
13-acetate (PMA) and oleoyl acetyl glycerol (OAG), mimic the ability of cx1-
adrenergic agonists to potentiate the ~-adrenergic induced response, PKC has 
been suggested to mediate this process in vivo. Likewise, if intracellular 
calcium is increased in pinealocytes by the use of Ca2+ ionophores or 
depolarizing concentrations of K+ (treatments known to activate PKC), ~-
adrenergic induced cAMP and cGMP production is enhanced. The fact that 
cx1-adrenergic receptor activation can potentiate cAMP and cGMP production 
stimulated by either cholera toxin or forskolin suggests that PKC exerts its 
effects either via the Gs protein and/ or adenylate cyclase and probably not via 
the ~-adrenoceptor. Activation of the cx1-adrenergic receptor does not appear 
to potentiate the ~-adrenergic induced increase in cAMP and cGMP by 
inhibiting the enzyme phosphodiesterase because cx-adrenergic potentiation 
of the ~-adrenergic induced response is still noted when high concentrations 
of phosphodiesterase inhibitors, e.g. IBMX, are added to pinealocyte cultures 
(Sugden and Klein 1988). 
The cx1-adrenergic potentiation of ~-adrenergic induced cGMP 
production appears to differ somewhat from that of cAMP. While an increase 
in intracellular calcium potentiates ~-adrenergic induced cGMP formation, 
activation of PKC alone had no effect (Sugden et al. 1985). Activators of PKC 
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can, however, potentiate the ~-adrenergic induced cGMP production in a dose 
dependent manner if intracellular Ca2+ is simultaneously increased. The 
exact role of Ca2+ in cGMP potentiation is not clear. 
Differential Regulation of cAMP by PKC Isozymes 
There are several isoforms of the enzyme PKC. The a., ~I, ~II, and y 
forms are usually present in large quantities within cells while the o, E, and~ 
forms are found in smaller amounts (Nishizuka 1988). Functional 
differences between these isozymes have only recently been discovered when 
it was determined that two of the PKC subspecies differentially affect cAMP 
production (Gusovsky and Gutkind 1991). In cells that only possess the a, PKC 
isozyme, e.g. NIH 3T3 cells, activation of PKC leads to an inhibition in 
forskolin-stimulated cAMP production. Activation of PKC in cells that 
possess both the a. and y isozymes, e.g. PC12 cells, results in a potentiation of 
cAMP generation (Gusovsky and Gutkind 1991). While only the a, and~ 
isoforms of PKC have been identified in the pineal gland (Yoshida et al. 1988), 
the exact isozyme involved in potentiating the ~-adrenergic induced cAMP 
and cGMP response has not been determined. In addition to the ability of 
PKC to potentiate cAMP generating systems, it remains a possibility that 
cAMP levels may be inhibited by receptors that activate the a. PKC isozyme. 
In the pineal gland, 80% of the PKC present is of the a. variety (Yoshida et al. 
1988). 
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Functional Implications of the a-Adrenergic Potentiation 
of the !l-Adrenergic Induced Response 
The exaggerated cAMP response initially caused by activation of both a-
and 13- adrenergic receptors by NE, or by PE-potentiation of cholera toxin 
stimulated cAMP production is of limited duration (Sugden et al. 1988; 
Sugden and Klein 1988). In both systems, cAMP levels declined to non-
potentiated (equivelent to 13-adrenergic induction alone) levels by 60 minutes. 
Activation of the al-adrenergic receptor quickly leads to its desensitization 
(Sugden et al. 1988). The physiological role of this large initial increase in 
cAMP may determine the extent of SNAT activity while the lower steady 
state levels of cAMP that follow function to maintain SNAT activity. It is 
known, for example, that the addition of 13-adrenergic antagonists to 
pinealocytes in vitro several hours after SNAT induction leads to a rapid 
decline in SNAT activity (Deguchi and Axelrod 1972). 
The potentiation in cAMP and cGMP levels seen after both a- and 13-
adrenergic receptor activation are paralleled by a two fold potentiation in 
SNAT activity (Klein et al. 1983). Whether an amplification in melatonin 
production also occurs remains controversial. In hamster pineal glands 
cultured in vitro, addition of PE potentiated the isoproterenol (Iso) -induced 
increase in melatonin production in the gland, while no potentiation in the 
amount of melatonin secretion into the media was noted (Santana et al. 
1989). In an in vivo experiment in which hamsters were injected with 
prazosin, an a-adrenergic antagonist, during the middle of the dark phase, an 
inhibition of pineal and serum melatonin was noted one hour after injection, 
while later time points (2 and 3 hours post-injection) were not affected 
(Stankov et al. 1990). In ovine pinealocytes cultured in vitro, PE potentiated 
the !so-induced production of melatonin within cells without any 
Potentiation in the cAMP response (Howell and Morgan 1991). 
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It appears that little PKC is necessary in pinealocytes to potentiate the 13-
adrenergic response. After downregulating PKC by 91 - 97%, 13-adrenergic 
induced cAMP was inhibited only 45-55%, while SNAT activity was not 
inhibited at all (Sugden 1991). This suggests that not all of the cAMP 
produced by the activation of both a- and 13-adrenergic receptors is necessary 
for the full induction of SNAT. The author of this study (Sugden 1991) 
concluded by stating " ... the physiological role of the al-adrenergic 
potentiation mechanism in regulating SNAT induction, and hence 
melatonin synthesis, in vivo is uncertain". 
Other Receptor /Binding Sites Present in the Rat Pineal Gland 
In addition to the well characterized adrenergic receptors, the pineal 
gland possesses many other receptor types whose role in indole metabolism is 
not known (Table 1). Many of these compounds appear to play a 
neuromodulatory role, i.e. they have no effect on their own but modulate 
adrenergic-induced SNAT activity and subsequent melatonin production. 
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Table 1. - Receptor /Binding Sites in the Pineal Gland 
Monoamines 
Receptor/ Affinity Receptor Effect 
binding site (Kct) numl:er of Function Ref. 
[*]ligand nM (Bmax) SCGx 
~-adrenergic 0.17 548 fmol increase Stirn. cAMP & 1 
[125I]iodo- /mg Bmax cGMP; increase 
Q'.ano12indolol protein SNAT activity & melatonin prod. 
a1-adrenergic 0.05 342 fmol increase Stirn. PI 2 
[125J]HEAT /mg Bmax hydrolysis & 
protein Ca2+ influx· I 
increase PKC 
activity 
<X2D- 1.40 71 fmol Not Inhibits SNAT 3 
adrenergic /mg determined activity 
[3H]rauwolscine protein 
D1- 0.56 974 fmol Not Unknown 4 
Dopaminergic /mg determined 
[3H]SCH 23390 protein 
D2- 0.18 37 & 630 Not attenuates NE- 5 
Dopaminergic & fmol/ determined stimulated 
[3H]s12iro12eridol 2.10 mg SNAT activity 
protein 
5HT2 1.26 193 Not Unknown 6 
[3H]SJ2i~rone fmol/mg determined 
protein 
1) Craft et al. 1985 (rat) 
2) Sugden and Klein 1984 (rat) 
3) Simmonneaux et al. 1991 (bovine); Alphs et al. 1984 (rat/function) 
4) Simmonneaux et al. 1990 (bovine) 
5) Govitrapong et al. 1984 (bovine); Govitrapong et al. 1989 (rat/function) 
6) Govitrapong et al. 1991 (bovine) 
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Table 1 - Continued 
Amino acids 
Receptor/ Affinity Receptor Effect 
binding site (Kd) numrer of Function Ref. 
[*]ligand nM (Bmax) SCGx 
Glutamate 534 4840 Not Inhibits NE- 7 
[3H]Glutamate fmol determined stim. SNAT 
/mg activity 
protein 
GABA 16.5 121 & Not Inhibits 8 
[3H]GABA & 2470 determined melatonin 
567 fmol/mg prod. 
protein 
Benzodiazepines 
Peripheral-type 2.46 24000 Decrease Enhances lso- 9 
Benzodiazepine fmol/mg Bmax stim. mel. 
[3H]Ro 5-4864 protein production 
Peripheral-type 4.40 2040 Not Unknown 10 
Benzodiazepine fmol/mg determined 
[3H]PK 11195 protein 
Central-type 2.80 124 Not Enhances Iso- 11 
Benzodiazepine fmol/mg determined stim. mel. 
[3H]flunit- protein production 
razenam 
7) Govitrapong et al. 1986 (bovine); Govitrapong et al. 1988 (rat/function) 
8) Ebadi and Chan 1980 (bovine); Rosenstein et al. 1989 (rat/function) 
9) Weissman et al. 1984 (rat); Winters et al. 1991 (rat/function) 
10) Suranyi-Cadotte et al. 1987 (human) 
11) Suranyi-Cadotte et al. 1987 (human); Winters et al. 1991 (rat/function) 
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Table 1 - Continued 
Peptides 
Receptor/ Affinity Receptor Effect Function Ref. 
binding site (Kd) number of 
[*]ligand nM (Bmax) SCGx 
VIP Not Not Not Stirn. SNAT 12 
[125I]VIP deter- deter- determined act. /melatonin 
mined1 mined1 production 
Arginine- Not Not Not Enhances NE- 13 
vasopressin 4-9 deter- deter- determined stim SNAT 
[35s]VP 4-9 mined1 mined1 activity 
Neuropeptide 1.00 40 Not See note2 14 
y fmol/mg determined 
[125I]NPY protein 
lNote: Autoradiographic visualization of [125J]VIP and [35S]VP4-9 binding in 
whole brain demonstrated the presence of a high concentration of VIP and 
VP4-9 binding sites in the pineal gland relative to other brain areas. KcI and 
Bmax values were determined for whole sections and did not differentiate 
between brain and pineal gland. 
2Note: The role of NPY in pineal gland function is controversial. Olcese 
(1991) reported that NPY is a potent inhibitor of NE-stimulated melatonin 
secretion in vitro (ICso 0.4 nM) while Vacas et al. (1987) reported that NPY 
(l0nM) enhances NE-stimulated melatonin production in vitro. 
12) Besson et al. 1986 (rat); Kaneko et al. 1980 (rat/function); Simonneaux 
et al. 1990 (rat/function) 
13) De Kloet et al. 1985 (rat); Stehle et al. 1991 (rat) 
14) Olcese 1991 (rat); Vacas et al. 1987 (rat/function) 
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Table 1- Continued 
Other 
Receptor/ Affinity Receptor Effect 
binding site (Kci) number of Function Ref. 
[*]ligand nM (Bmax) SCGx 
Estrogen 0.42 1.6 fmol Decrease Unknown 15 
nuclear /mg Bmax 
complex tissue 
[3H]estradiol 
Sigma opiate Not Not Not Unknown 16 
[3H] 1,3-di-ortho- deter- deter- determined 
totiI-gyanidine mined1 mined1 
M uscarinic- 0.01 32 fmol No change Stirn. PI 17 
Cholinergic /mg hydrolysis 
[3HlONB protein 
A2-Adenosine 51 1060 Not Enhances NE- 18 
[3H]NECA fmol/mg determined stimulated mel. 
protein prod. 
1NOTE: Autoradiographic visualization of [3H]DTG binding in whole brain 
demonstrated the presence of a high concentration of cr binding sites in the 
pineal gland relative to other brain areas. Kd and Bmax were not determined. 
15) Cardinali 1977 (rat) 
16) Jansen et al. 1990 (rat) 
17) Taylor et al. 1980 (ovine and rat); Laitinen et al. 1989 (rat-function) 
18) Sarda et al. 1989 (rat); Vasas et al. 1989 (rat-function) 
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Melatonin - Its Role In Vivo 
Over the course of a year, animals in their natural habitat are subjected 
to changes in day length. In seasonally reproductive animals, e.g sheep and 
hamster, the length of the photoperiod that an animal is exposed to per day 
determines reproductive success. This is most clearly seen in the hamster 
where a minimum of 12.5 hours of light is required to maintain normal 
testicular size (Elliott 1976). If the animal is exposed to anything less than 12.5 
hours of light, the testes will begin to regress and spermatogenesis is inhibited 
(Elliott 1976). This inhibitory effect of shortened photoperiod can be reversed 
by removal of the pineal gland (Reiter 1972). The fact that testicular atrophy 
can be induced in pinealectomized hamsters by a daily regimen of melatonin 
administration (3 injections of 25 ug at three hour intervals), suggests that 
melatonin is responsible for this inhibition in vivo (Tamarkin et al. 1977). It 
should be noted, however, that melatonin's role in reproductive function is 
not always inhibitory. In sheep, exposure to short days stimulates 
reproductive activity (Wayne et al. 1990). Mating in this species occurs in the 
fall resulting in lambs that are born in the spring. Administration of 
melatonin to female sheep in the summer has been reported to advance the 
onset of cyclical ovarian activity (Nowak et al. 1990). 
The site of action of melatonin within the central nervous system is 
not known. Receptors for melatonin have only recently been characterized 
and appear to be present in the pars tuberalis and SCN regions of the brain 
(Reppert et al. 1988; Williams and Morgan 1988). It has been postulated that 
melatonin acts via the SCN to alter the release of gonadotropin releasing 
hormone (GnRH) and thereby alters reproductive function. 
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The human pineal gland, like the pineal gland of all other animals, has 
elevated levels of melatonin secretion at night (Lynch et al. 1978). The 
function of this hormone in humans is not clear however. Administration 
of exogenous melatonin (lmg/kg) to human subjects during the day has been 
reported to induce subjective sleepiness (Lieberman et al. 1984). A role for 
melatonin in seasonal affective disorder (SAD), a form of clinical depression 
noted during the winter months when daylength is shorter, has been 
postulated (Thompson et al. 1990). Symptoms of this disorder include a 
greater need for sleep, weight gain, and a craving for carbohydrates. Therapy 
for this disorder includes exposing the patient to high intensity light (Oren et 
al. 1991). Melatonin levels abruptly drop in humans subjected to bright light 
during the night when melatonin levels are normally high (Thompson et al. 
1990). 
Excitatory Amino Acids / Pharmacology 
Within the human brain, there are an estimated 1012 - 1014 neuronal 
synapses responsible for the transduction of chemical information between 
cells (Purves and Lichtman 1985). Inhibition at these synapses are mediated 
by a number of well established neurotransmitters including dopamine, 
GABA, norepinephrine, and serotonin. By contrast, most excitatory synaptic 
transmission appears to be mediated by a single compound or family of 
compounds chemically related to the amino acid L-glutamate. The excitatory 
properties of glutamate were first demonstrated in 1954 when it was reported 
that the injection of L-glutamate or L-aspartate directly into the brain or 
carotid artery of laboratory animals resulted in seizures (Hayashi 1954). The 
earlier observation that tissue glutamate levels were highest in the brain had 
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already suggested an important role for glutamate in neuronal function 
(Waelsch 1951). A known intermediate in the tricarboxylic acid cycle, 
glutamate was believed to be linked to the high metabolic demands of the 
tissue. Later studies, noting the chemical similarities between this amino acid 
and the known neuroinhibitor GABA, suggested that glutamate had, in 
addition to its metabolic role, a neuroactive role. Early reports describing an 
inhibitory role for glutamate noted its ability to initiate spreading depression 
within the brain (Purpura et al. 1959; Van Harreveld 1959). However, these 
studies were not substantiated and evidence accumulated for glutamate's role 
as an excitatory agent. It had been demonstrated, for example, with the use of 
intracellular recording techniques that both L-glutarnate and L-aspartate 
exerted a depolarizing effect on spinal cord neurons (Curtis et al. 1959). 
Unlike other known neurotransmitters, however, glutamate was found to 
stimulate neurons in nearly all areas of the central nervous system tested, 
including brain stern neurons (Curtis and Koizumi 1961), cerebral cortical 
neurons (Phillis and Krnjevie 1961) and thalarnic neurons (Curtis and Davis 
1962). To earlier investigators, this non-specific nature of L-glutarnate and the 
fact that high concentrations (1Q-3 to 10-4 M) were needed to evoke a response 
made its role as a neurotransmitter seem unlikely. In addition, no specific 
enzymatic system capable of terminating glutamate's stimulatory action 
appeared to be present, suggesting that if a separate excitatory system did exist 
it was not glutamate, but a related compound that acted as the endogenous 
transmitter. Extensive structure-activity studies were undertaken in an 
attempt to determine the functional groups responsible for glutamate's 
stimulatory effect. These studies resulted in the discovery of several new 
"excitants" including N-rnethyl-D-aspartate (NMDA), L-cysteic acid, D-
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homocysteic acid, and D,L-aminoadipic (Watkins 1962). For many years the 
nature of glutamate's excitatory action within the CNS remained undefined. 
In addition to the obvious differences between glutamate and other known 
neurotransmitters, inhibition of glutamate's stimulatory effect had not been 
demonstrated with the use of specific receptor antagonists. Early reports of 
regional differences (spinal cord and cerebral cortex) in the rank order 
potencies of various glutamate analogues were the first suggestion of a more 
specific nature of action for this amino acid (Curtis and Watkins 1960; 
Krnjevic and Phillis 1963), but the data were not conclusive. One of the 
first definitive reports of the specific nature of glutamate's stimulatory action 
came several years later when it was demonstrated in the cat spinal cord that 
ventral horn neurons were significantly more responsive to L-aspartate than 
L-glutamate, while dorsal horn neurons preferentially responded to L-
glutamate (Duggan 1974). In another study that same year, NMDA and kainic 
acid were proposed to act at different receptor sites; NMDA appearing to act at 
an "aspartate preferring" site and kainic acid acting at a "glutamate 
preferring" site (McCulloch et al. 1974). Relatively selective antagonism of L-
glutamate and L-aspartate responses had already been obtained with the 
compounds L-glutamic acid diethyl ester (GDEE) and 3-amino-1-
hydrxpyrrolidone (HAP), respectively (Haldemann and McLennan 1972) 
further supporting the idea of receptor subtypes. In addition, membrane 
binding studies utilizing glutamate demonstrated for the first time that 
glutamate binding was saturable, of reasonably high affinity, and inhibited by 
other neuroexcitatory amino acids (Michaelis et al. 1974; Roberts 1974) 
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NMDA Receptor 
It was becoming increasingly evident that glutamate's actions in _brain 
were mediated by at least two distinct receptor subtypes. The first 
unequivocal report of receptor differentiation was the demonstration by 
Evans et al. that NMDA responses could be selectively inhibited by the 
divalent cation Mg2+. Responses to quisqualate and kainate were unaffected 
by concentrations of Mg2+ as high as 20mM (Evans et al. 1977). It was also 
noted at this time that D-alpha-aminoadipate (DAA), a compound previously 
shown to have weak excitatory action in its racemic form, selectively 
inhibited responses to NMDA (Biscoe et al. 1977). It was later discovered that 
substitution of the carboxy group of DAA with a phosphonate group 
produced an antagonist, D(-)-2-amino-5-phosphonopentanoate (APS), that 
was much more selective and potent than DAA (Davies et al. 1981). This 
antagonist and several other related antagonists were soon superceeded in 
potency by heterocyclic derivatives of APS which included the compound 3-
(( + )-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), an antagonist 
approximately 5 times more potent than APS (Harris et al. 1986) More 
recently another heterocyclic derivative of APS, CGS-19755 was found to be an 
even more potent antagonist at the NMDA site (Lehmann et al. 1988). 
NMDA Receptor - Ionophore Complex 
In addition to the transmitter recognition site which binds compounds 
such as NMDA, DAA, APS, CPP, and CGS-19755, several other sites are 
present within the receptor -ionophore complex. These include (a) a Mg2+ 
binding site (Mayer et al. 1984; Nowak et al. 1984); (b) an allosteric regulatory 
site that binds glycine (Johnson and Ascher 1987; Kleckner and Dingledine 
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1988); (c) a phencyclidine binding site (Anis et al. 1983; Coan and Collingridge 
1987; Wong et al. 1986); (d) a Zn2+ binding site (Peters et al. 1987; Westbrook 
and Mayer 1987); and (e) a polyamine binding site (Ransom and Stec 1988). 
Non-NMDA Receptors: AMP A and Kainate 
Often referred to as the non-NMDA receptors, a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) and kainate receptors have not 
been clearly distinguished from one another on the basis of selective 
antagonist binding. It was the observation of differences in rank order 
potencies when receptors were labeled with either [3H] kainate (domoate> 
kainate> quisqualate>> L-glutamate) (Monaghan and Cotman 1982) or [3H] 
AMPA (quisqualate> AMPA L-glutamate> kainate) (Honore et al. 1982) that 
first supported the idea of separate receptors. The most convincing evidence 
for separate kainate and AMPA receptors came from studies in which the 
anatomical localization of [3H] kainate and [3H] AMP A binding within the 
brain was examined. It was demonstrated that kainate binding is 
concentrated in the hippocampal CA3 stratum lucidum, deep cerebral cortical 
layers, striatum and granule cell layer of the cerebellum (Monaghan and 
Cotman 1982; Unnerstall and Wamsley 1983) whereas [3H] AMPA binding 
sites are more numerous in the CAl stratum radiatum, outer cortical layers, 
lateral septum, and molecular layer of the cerebellum (Monaghan et al. 1984; 
Olsen et al. 1987). The recent development of the antagonist 6-cyano-7-nitro-
quinoxaline-2,3-dione (CNQX) has provided specific inhibition of a 
kainate/ quisqualate response but could not distinguish between the two 
receptor subtypes (Honore et al. 1988). Another recently developed 
antagonist, 2-amino-3-[3-(carboxymethoxy)-5-methylisoxazol-4-yl]propionic 
acid (AMOA), has been reported to selectively inhibit kainate responses 
without significantly decreasing AMPA-induced responses (Frandsen et al. 
1990). 
APB Receptors 
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In the early 1980's the antagonistic properties of APB had been reported 
at several glutamate using synapses (Collins 1982; Davies and Watkins 1982; 
Lanthorn et al. 1984). APB did not, however, appear to antagonize the effects 
of NMDA, quisqualate, kainate, and L-glutamate if applied simultaneously, 
suggesting that APB was acting at a fourth receptor subtype (Evans et al. 1982). 
Recent evidence suggests a presynaptic site of action for APB (Forsythe and 
Clements 1988). 
Glutamate Metabotropic/ Trans-ACPD Receptor 
Glutamate has been shown to stimulate the production of inositol 
phosphate in various neuronal preparations (Nicoletti et al. 1986; Sladeczek et 
al. 1985). When the pharmacological properties of the receptor mediating this 
effect were examined, it was noted that L-glutamate, quisqualate, ibotenate, 
and 1-amino-cyclopentyl-1,3-dicarboxylate (ACPD) stimulated inositol 
phosphate production while NMDA, AMP A and kainate did not (Monaghan 
et al. 1989; Nicoletti et al. 1986). This stimulation of inositol phosphate 
production could not, however, be blocked by known quisqualate/kainate or 
NMDA antgonists, indicating that this receptor differed from the known 
glutamate receptors (Schoepp and Johnson 1988). ACPD, the most selective 
agonist at this receptor, appears to be linked to a pertussis toxin-sensitive G 
protein that mediates the production of inositol phosphates. This receptor 
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appears to be important during normal neuronal development and synaptic 
stabilization as demonstrated by the fact that receptor efficacy decreased after 
synaptogenesis and reappeared following deafferentation (Schoepp et al. 
1990). 
Molecular Biology of Glutamate Receptors - Are There 
More than Five Receptor Subtypes? 
Glutamate-evoked responses at neuronal synapses are mediated by the 
opening of ion channels (ionotropic receptors) and/or the stimulation of 
second messenger systems (metabotropic/ ACPD receptors). Glutamate 
receptor subtypes linked to ion channels include the AMPA, kainate, NMDA 
and APB receptors. The AMP A and kainate receptors have been 
demonstrated to gate ion channels that permit the influx of monovalent 
cations such as Na+ and K+, while the NMDA receptor complex is believed to 
modulate a voltage-sensitive Ca2+ channel (Watkins et al. 1990). The recent 
cloning of the genes for several of the glutamate receptor subtypes suggests a 
more complicated arrangement. It is now known that there are at least 4 
subtypes of AMPA receptor, refered to as GluR-A GluR-B, GluR-C, GluR-D 
(or GluR-1, -2, -3, -4) (Hollmann et al. 1989; Keinanen et al. 1990). In addition, 
the cDNA nucleotide sequence of each receptor subtype possesses 115 base 
pairs that are found to exist in 1 of 2 sequence versions. These two versions 
are refered to as "flip" and "flop" (Sommer et al. 1990). This increases the 
number of molecular species to 8. Each receptor subtype demonstrates a 
unique mRNA expression pattern in the brain (Keinanen et al. 1990). 
While these receptors display typical AMP A pharmacology (Keinanen 
et al. 1990), the expression of two of the subtypes, GluR-A or GluR-C, produces 
ion channels that are highly permeable to Ca2+ (not an AMPA-like 
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characteristic) (Hollmann et al. 1991). If GluR-B is expressed along with GluR-
A or GluR-C an ion channel that is impermeable to Ca2+ is formed 
(Hollmann, et al. 1991). This led Richard Miller to state that " .. .if the potential 
number of kainate / AMPA receptors available from combinations of 
multiple gene products and splice varients are considered, the resulting 
diversity is truly mind boggling ... although it could be said that all these 
receptors will be activated by excitatory amino acids, wide variations in their 
pharmacology and biophysical properties should be expected" (Miller 1991). 
While each receptor subtypes forms a functional ion channel when 
expressed alone, the composition of native receptors is not known. Three 
subtypes of kainate receptor have also been cloned, GluR-E (GluR-5) (Bettler 
et al. 1990), GluR-F (GluR-6) (Egebjerg et al. 1991) and KA1 (Werner et al. 
1991), Like the AMPA receptor, each receptor subtype possesses a unique 
anatomical distribution. KA1, while binding [3H]kainate, does not appear to 
be functional in electrophysiological studies. The metabotropic receptor has 
also been cloned (Masu et al. 1991), and may exist in multiple forms (Henley 
and Johnston 1991). The glutamate binding site of the NMDA receptor 
complex has been the most recent glutamate receptor cloned (Kumar et al. 
1991). 
Glutamate Uptake Sites 
After it is released from nerve terminals glutamate is removed from 
the extracellular space by uptake into neurons and glia. Distinguished by 
their ion dependencies, two distinct systems for the uptake of glutamate exist. 
The first site to be described, a Na+-dependent uptake site, displayed high 
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affinity for the glutamate analogues D-aspartate, L-aspartate, threo-~-
hydroxyaspartate (TBH), and L-cysteine sulfinic acid . Early binding studies 
reported K(i values ranging from 2400 - 4000 nM and Bmax values ranging 
from 75000 - 336000 fmol/mg protein (Foster and Fagg 1984). A more recent 
autoradiographic study utilizing D-[3H]aspartate has characterized a Na+-
dependent binding site with a Kd = 577 nM and a Bmax = 3710 fmol/mg 
protein (Anderson et al. 1990). Anatomical heterogeneity in L- and D-TBH 
inhibition of D-[3H]aspartate binding has suggested that two distinct 
population of Na+-dependent binding sites may exist (Anderson and Vickroy 
1990). The process of glutamate uptake into the cell is electrogenic. When a 
single glutamate anion is transported into a cell, it is accompanied by the 
simultaneous uptake of three Na+ ions while one K+ ion is transported out 
of the cell (Barbour et al. 1988; Brew and Attwell 1987). Because one positive 
charge enters the cell for every glutamate taken up by the carrier, an inward 
current is generated. The second class of uptake sites, the CI--dependent sites, 
are not as numerous as the Na+-dependent sites. Saturation analysis of 
[3H]glutamate binding in the presence of c1- yield a binding site with a Kd = 
315 nM and Bmax = 656 fmol/mg protein (Anderson et al. 1990). Binding at 
this site is most potently inhibited by L-glutamate, L-a-amino adipic acid, 
quisqualate, and L-serine-o -sulfate. 
In addition to the Na+ and c1--dependent glutamate uptake sites 
present on the plasma membrane, uptake sites for glutamate are present on 
synaptic vesicles. Uptake at these sites is Na+-independent but potentiated by 
the presence of c1-. These binding sites have an affinity for glutamate in the 
millimolar range (Km = 2mM) and do not transport aspartate or other 
glutamate analogues (Carlson et al. 1989). 
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Glutamate Induced Neurotoxicity 
Excitotoxicity, now a well known property of glutamate, was first 
reported by Lucas and Newhouse (1957), when it was demonstrated that large 
amounts of glutamate injected subcutaneously in mice caused extensive 
retinal damage. The process of L-glutamate induced cell death is believed to 
be mediated by several different mechanisms initiated by the binding of 
glutamate to the NMDA, kainate, and possibly AMPA receptors. One 
mechanism for this unique type of neurotoxicity, which damages only 
neuronal cell bodies and not axons of passage, is believed to be an excess 
influx of Ca2+ into cells that results in the stimulation of various Ca2+ 
dependent proteases (Choi 1987). Others have suggested that a passive influx 
of c1- ions may be responsible for the associated cell swelling and death 
(Olney et al. 1986; Rothman 1985). Still more recently Coyle and collegues 
have suggested that glutamate induced neurotoxicity may be mediated by 
oxidative stress (Murphy et al. 1989). Excitatory amino acids have been 
suggested to play a role in such neurodegenerative diseases as Huntington's 
chorea (McGeer and McGeer 1976), epilepsy (Sloviter 1983), lathyrism 
(Spencer et al. 1986), and Alzheimer's disease (Greenamyre and Young 1989). 
Attenuation of glutamate induced neuronal damage has been demonstrated 
with the use of both competitive and non-competitive glutamate antagonists 
(Boast et al. 1988; Woodruff et al. 1987). 
Excitatory Amino Acid Modulation of Noradrenergic/ 
Pineal Function 
A novel function for excitatory amino acids was first suggested by 
Baudry and collegues who noted that glutamate and its analogues inhibited 
carbachol and histamine induced [3H]inositol phosphate accumulation in the 
hippocampus (Baudry et al. 1986). A similiar observation was made in 
prefrontal cortex (Noble et al. 1989). NE-induced inositol phosphate 
production did not appear to be inhibited by glutamate. It was noted by 
others, however, that if the assay was modified and glutamate was added 
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prior to the incorporation of [3H]inositol into the larger phospholipid 
molecule, glutamate could the NE-stimulated synthesis of [3H]IP3 (Jope and Li 
1989). How glutamate inhibits this norepinephrine induced synthesis is not 
known, but a reduction in the number of a1-adrenergic receptors, known to 
mediate the NE-induced IP3 production, does not appear responsible for this 
decrease (Nicoletti et al. 1986). In agreement with the observation that 
glutamate decreases NE-induced phosphoinositide hydrolysis, it has been 
demonstrated in vitro that SNAT activity can be decreased by the addition of 
glutamate to NE-stimulated pineal glands (Govitrapong and Ebadi 1988). The 
recent observation that photoreceptors (from which mammalian pinealocytes 
evolved) release glutamate upon stimulation suggests a possible feedback 
mechanism that can be applied to the pineal gland (Copenhagen and Jahr 
1989). 
This dissertation, which hypothesizes a neuromodulatory role for 
glutamate in pineal gland function, examines several aspects of glutamate -
pineal gland interaction. In the first series of experiments, the amino acid 
content of the pineal gland over the 24 hour light-dark cycle is examined. 
The effect of sympathetic denervation on amino acid content within the 
gland was assessed to determine if maintenance of amino acid content was 
dependent on an intact innervation. Anatomical localization of glutamate 
within the pineal gland was determined with the use of semiquantitative 
imm unocytochemistry. 
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In the second series of experiments the presence of a binding site for 
[3H]glutamate in pineal gland was ascertained with the use of in vitro 
receptor autoradiography. To determine if binding sites were located on 
either sympathetic terminals or other pineal gland cell types, [3H]glutamate 
binding was also examined in sympathetically denervated pineal glands. Day 
-night differences in [3H]glutamate binding site number was determined by 
examining [3H]glutamate binding in pineal glands obtained from animals 
sacrificed during the middle of the light and dark periods. 
The third series of experiments examines the effect of glutamate and 
various glutamate agonists on the adrenergic-stimulated secretion of the 
pineal gland hormone melatonin in vitro. 
CHAPTER III 
PINEAL GLAND AMINO ACIDS IN THE RAT I. 
IMMUNOCYTOCHEMISTRY AND CIRCADIAN BIOCHEMICAL ANALYSIS 
AFTER SUPERIOR CERVICAL GANGLIONECTOMY 
Abstract 
Semiquantitative immunocytochemistry was employed to determine 
the anatomical distribution of glutamate- and glutamine-like 
immunoreactivity within the pineal gland of the rat. The greatest amount of 
glutamate- and glutamine-like immunoreactivity was found over 
pinealocytes and glia respectively. At the subcellular level, glutamate-like 
immunoreactivity was highest over pinealocyte mitochondria and lowest 
over lipid inclusions. Pineal levels of glutamate and glutamine as measured 
by high performance liquid chromatography (HPLC), did not vary over a 
light-dark cycle. Superior cervical sympathetic denervation, which abolishes 
pineal gland melatonin synthesis, resulted in a nearly 50% reduction in 
pineal glutamate levels, but had no effect on levels of glutamine and taurine. 
Other amino acids (alanine, arginine, aspartate, serine) were reduced between 
16-36% following sympathectomy. 
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Introduction 
The mammalian pineal gland, a transducer of photoperiodic 
information, synthesizes and secretes the hormone melatonin in highest 
quantities at night (Klein and Weller 1970). The rate-limiting enzyme in the 
synthesis of melatonin, SNAT, is activated by the nocturnal release of the 
neurotransmitter NE from sympathetic nerve terminals located within the 
pineal gland. Activation of this enzyme leads to the conversion of the 
indoleamine serotonin (SHT) to N-acetylserotonin. A second enzyme, 
hydoxyindole-O-methyltransferase subsequently methylates NAS to form the 
methoxyindole, melatonin (Klein 1985). The resulting circadian rhythms in 
these indole derivatives are driven by clock mechanisms in the SCN and are 
dependent on an intact sympathetic innervation (Moore 1978). 
Recently, numerous other factors have been implicated in the control 
of melatonin synthesis and secretion. In addition to monoamines (Ebadi and 
Govitrapong 1986), neuromodulatory peptides such as vasoactive intestinal 
peptide (VIP), neuropeptide Y (NPY), vasopressin (VP) and oxytocin (OT) 
have varying effects on SNAT activity and melatonin secretion (Olcese 1991; 
Simonneaux et al. 1990; Simonneaux et al. 1990; Stehle et al. 1991). Levels of 
OT and VP, as well as other neuropeptides such as somatostatin and an 
immunoreactive arginine vassopressin-like peptide have been reported to 
vary with time and/ or physiological status of the pineal gland implying a 
functional relationship to melatonin synthesis (Liu and Burbach 1987; Liu 
and Burbach 1988; Moujir et al. 1990; Webb et al. 1984). These observations 
clearly indicate that the mechanisms regulating synthesis and secretion of 
melatonin in the pineal gland are complex and multifaceted. 
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To date, little information is available on a possible role for 
neuroactive amino acids in modulating melatonin synthesis/secretion in the 
pineal gland. Two such amino acids, glutamate and taurine, are present in 
high concentrations within the pineal (Govitrapong and Ebadi 1988; McNulty 
et al. 1990; Nir et al. 1973), and glutamate binding sites have been 
characterized in the gland (Govitrapong et al. 1986; Kus et al. 1990). 
Administration of glutamate to glands in vitro inhibited adrenergic receptor 
activation of SNAT and melatonin secretion (Govitrapong and Ebadi 1988; 
Kus et al. 1991). Taurine has also been shown to affect SNAT activation by 
adrenergic mechanisms, but in a stimulatory fashion (Wheler et al. 1979). An 
hypothesized functional relationship of these neuroactive amino acids with 
adrenergic-mediated indole metabolism was further suggested by 
developmental changes in day-night levels of amino acids coincident with 
the ontogenetic onset of circadian rhythms in indole constituents leading to 
the production of melatonin (McNulty et al. 1990). 
The purpose of this investigation was to provide semiquantitative 
immunocytochemical data on the distribution of glutamate and glutamine 
within the different cellular compartments of the rat pineal gland. The 
subcellular localization of glutamate within pinealocyte organelles was also 
analyzed. A second aim of the study was to determine if steady state levels of 
free amino acids exhibit circadian rhythms. In view of the above cited studies 
suggesting an interaction of glutamate with adrenergic receptor mechanisms, 
we also investigated the effects of sympathetic denervation on amino acid 
levels over the 24 hour light-dark cycle. 
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Materials and Methods 
Animals 
A total of 112 adult male Sprague-Dawley rats (Sasco-King, Oregon, WI) 
were used in this study. Animals were housed in a fully accredited animal 
care facility and were used according to the recommendations in the Guide 
for the Care and Use of Laboratory Animals and The Guidelines of the 
Institutional Animal Care and Use Committee at Loyola University Medical 
Center. All animals were entrained for 4 weeks to programmed light:dark 
cycles in the animal room (1000 lux) or in environmental chambers 
illuminated by Vita lights (2200 lux) connected to automatic 24 hour timers. 
Temperature in the environmental chambers was regulated by fans. All 
animals had access to food and water ad libitum. For the experiments 
measuring effects of denervation of pineal free amino acids, animals (n=6 per 
time point per group) were sacrificed by rapid decapitation at 6 time points 
over the light:dark cycle (mid-light, mid-dark, and 1 hour either side of lights 
on and lights off). A dim red light (Kodak filter 1A) was used for dark-time 
sampling. Animals used for immunocytochemical analysis were sacrificed by 
cardiac perfusion after sodium pentobarbitol anesthesia. 
Superior Cervical Ganglionectomy · Procedures 
For bilateral removal of the superior cervical ganglia, animals (n=36) 
were anesthetized with sodium pentobarbitol (65 mg/kg), placed in an aseptic 
surgical field, and a ventral midline incision made on the neck. The carotid 
sheath and contents were exposed and the sympathetic chains followed 
rostrally to the superior cervical ganglia (SCG). The ganglia were removed 
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bilaterally with fine forceps and micro-scissors and the incision closed with 
sterile silk suture. Sham operations (n=36) involved all of the above except 
removal of the ganglion. An additional unoperated control group (n=36) was 
included in the study. A 4 week recovery period from the surgery was 
allowed and the animals checked for ptosis to confirm superior cervical 
ganglionectomy (SCGX). Individual glands were also assayed for 
norepinephrine by HPLC (see below) to further confirm degeneration of 
noradrenergic terminals. 
High Performance Liquid Chromatography (HPLC) 
General methods for HPLC have been described elsewhere (McNulty et 
al. 1987; McNulty et al. 1990). Briefly, pineal glands were quickly dissected, 
frozen on dry ice, and stored at -70°C until assayed. Glands were 
homogenized in cold 0.05 M monobasic phosphate buffer (pH 7.0). 
Homogenates were centrifuged at 15,000X g for 2 minutes and aliquots of 
supernatant were injected directly into the chromatographic system 
consisting of a Rainin Rabbit pump, a Rheodyne 7125 inject port with a 100 
ml sample loop, and a C18 reverse phase column (10 cm X 4.6 cm, 3 mm 
particle size, Rainin Instruments, Woburn, MA). Levels of free amino acids 
were determined using pre-column derivatization with o-phthaldialdehyde 
(OPA; Sigma) as described previously (McNulty et al. 1990). Fluorescence 
emitted by the derivatized compounds was measured with a LDC 
Fluoromonitor III (Milton Roy, Riviera Beach, FL) equipped with standard 
excitation (340-380 nm) and emission (418-700 nm) filters. The detector was 
connected to a HP 3390A integrator (Hewlett Packard, Avondale, PA) used to 
analyze the peaks. The mobil phase consisted of 0.1 M monobasic sodium 
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phosphate mixed with HPLC-grade methanol (32 %) and delivered at a rate of 
1.0 ml/min. A separate chromatograph was used to measure pineal levels of 
NE as described previously (McNulty et al. 1990). Briefly, NE was separated 
using a C18 reverse phase column and electrochemically detected with a 
glassy carbon electrode (0.7 V vs Ag/ AgCl reference electrode) connected to a 
BAS LC-4B electrochemical transducer. The mobil phase comprised 0.1 M 
sodium phosphate with 3 mM octanesulfonic acid (Kodak) and 4% methanol 
delivered at 1.0 ml/min with a 110A Altex metering pump. Identification of 
eluted compounds were based on retention times, and the concentration of 
samples were determined by comparison with synthetic standards made daily 
from stock solutions. Aliquots of supernatant were reserved for the 
measurement of soluble proteins according to the method of Lowry et al. 
(1951). 
Quantitative Electron Microscopic Immunocytochemistry. 
Electron microscopic imm unocytochemistry of amino acids followed 
previously published procedures (Ji et al. 1991; Ottersen 1988; Somogyi et al. 
1986; Storm-Mathisen and Ottersen 1990). Animals (n=4) were anesthetized 
with pentobarbital (65 mg/kg) during the middle of the photoperiod and 
perfused through the left cardiac ventricle with the fixative solution 
comprising 2.5 % glutaraldehyde and 1 % paraformaldehyde in 0.1 M sodium 
phosphate buffer (pH 7.4). The fixative perfusion was preceded by a brief 
flush of a 2% solution of dextran (MW 70,000) in the same buffer. After 
dissecting the glands, they were postfixed in the 
glutaraldehyde/paraformaldehyde fixative for 3 hours before post-fixation for 
1 h with 1 % osmium tetroxide in phosphate buffer. Glands were 
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subsequently dehydrated in ethanol and propylene oxide, then infiltrated and 
embedded in epoxy resin (Durcupan). Ultra-thin sections (70-80 nm) were cut 
with a diamond knife and mounted on Ni mesh grids for post-embedding 
immunocytochemical procedures. Sections treated with periodic acid and 
sodium periodate were exposed to the primary antisera, diluted 1:500. The 
sera had been raised against either glutamate (code 03; (Ji et al. 1991)), or 
glutamine (code 34; (Laake et al. 1986)) coupled to carrier protein by 
glutaraldehyde following the procedure originally described by Storm-
Mathisen et al. (Storm-Mathisen et al. 1983). The secondary antibodies were 
coupled to 15 nm gold particles. The specificity of labelling was monitored in 
each experiment by analysis of test sections (Ottersen 1987) that had 
accompanied the tissue sections throughout the immunocytochemical 
procedures. These test sections carried model conjugates prepared by reacting 
different amino acids with brain protein in the presence of glutaraldelhyde. 
Each antiserum reacted selectively with the amino acid used for 
immunization as demonstrated in a series of previous reports (Ji et al. 1991; 
Ottersen 1988). As a further specificity control the antisera were preadsorbed 
with their respective antigens. This was done by adding 400 uM 
glutaraldehyde complexes of either glutamate or glutamine to the appropriate 
antiserum on the day before the immunocytochemical incubation (Ji et al. 
1991; Ottersen 1988). This procedure reduced the gold particle density over 
the tissue to a level similar to that over tissue-free resin. Labelling was also 
abolished when a pre-immune serum was used in lieu of the primary 
antiserum. 
Micrographs of the sections were made with an Hitachi H-600 electron 
microscope at primary magnifications of 8,000X and 20,000X. Counts of the 
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area densities of gold particles over specific cell compartments were obtained 
by computerized image analysis using a Mac Hex running NIH Image 
software. The freehand-selection tool was used to obtain profile areas of 
specific cellular compartments and the number of gold particles counted 
within that profile area after thresholding the gray-scale to include only the 
electron dense gold particles. From 10-50 profiles of each cell type were 
analyzed at 8,000X with 5-10 areas measured in each profile. Additional 
measurements of area density of gold particles in mitochondria, cytoplasm 
(n=22) were obtained from micrographs taken at 20,000X. Area densities for 
pinealocyte cytoplasm and mitochondria obtained from low and high 
magnification micrographs did not differ significantly. 
Statistics 
Means and standard errors of amino acid levels were calculated and 
grouped according to treatment and time of sacrifice. The F-statistic for the 
effect of time was calculated using a one-way ANOV A followed by Bonferroni 
simultaneous confidence intervals. The F-statistic for the effect of time and 
treatment was calculated using a two-way ANOVA. For 
immunocytochemical data the F-statistic between groups was calculated using 
a one-way analysis of variance. A p <0.05 was considered significant. 
Results 
Pineal Gland Free Amino Acids and Protein 
Circadian analysis 
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Estimates of the steady state levels of free amino acids in the pineal 
gland of rats entrained to a 10:14 hour light-dark cycle revealed that glutamate 
and taurine occurred in the highest concentrations (Table 1). Only one of the 
amino acids assayed, alanine, exhibited significant differences over the light-
dark cycle (Fig. 1 and Table 2). Steady state levels of other amino acids assayed 
(glutamate, taurine, glutamine, aspartate, arginine, and serine) did not vary 
significantly over the 24 hour light-dark cycle (Figs. 2, 3 and Table 2). There 
were no differences in protein content of the glands related to time of sacrifice 
over the light-dark cycle (data not shown). 
Effect of SCGx 
Variables from sham operated animals were not significantly different 
from unoperated controls at any time point based on two-way ANOVA. Data 
points from both the control and sham operated animals did not differ 
significantly and the data were therefore combined (Table 1). Bilateral SCGx 
significantly decreased pineal levels of glutamate, aspartate, alanine, and 
arginine over the light-dark cycle (Figs. 1, 2 and Table 3). Sympathetic 
denervation of the gland had the greatest effect on glutamate, decreasing 
levels by 48% for samples pooled over the light:dark cycle. By comparison, 
levels of aspartate, alanine, and arginine were decreased to a lesser extent (16-
36%) following SCGx, while the levels of serine were only marginally affected 
(p=0.10) and glutamine, taurine, and protein were unaffected by denervation 
(fig. 3 and Table 3). Sympathectomy also abolished the circadian changes in 
pineal alanine content (Fig. 1). NE levels were not detectable in any of the 
sympathectomized glands (data not shown). 
Immunocytochemistry 
Glutamate 
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Specific immune-staining for glutamate was found in each of the cell 
types present within the pineal gland (Figs. 4, 6). Semi-quantitative analysis 
of gold particle densities revealed the highest concentration of glutamate 
immuno-staining over pinealocytes (Figs. 4, 6). The densities of glutamate 
immunolabelling did not differ significantly between glia, endothelia and 
sympathetic nerve elements. Analysis of the subcellular cytoplasmic 
distribution of glutamate-immunolabel within pinealocytes indicated that 
lipid inclusions were nearly devoid of glutamate immunolabeling and 
mitochondria had slightly higher label density compared to the surrounding 
cytoplasm (Fig. 7). 
Glutamine 
Specific glutamine immuno-staining had the highest area density of 
label in glia, and was only slightly above background in neural elements (Figs. 
5, 6). The overall density of label in each of cell types was lower than that of 
glutamate. 
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Discussion 
As it is in other brain regions, glutamate is present in high 
concentration within the rat pineal gland. Immunocytochemically localized 
within all cell types present in the gland, glutamate is likely to have several 
functions. In addition to being a reaction product of the citric acid cycle, 
glutamate is involved in the detoxification of ammonia, and serves as a 
precursor for the synthesis of glutathione, proteins and GABA (Meister 1979). 
The presence of these high levels of glutamate in the rat pineal gland may 
also be related to the gland's phylogenetic transition from a photoreceptive 
organ. Comparative anatomical and histochemical studies have presented 
strong evidence that mammalian pinealocytes have evolved from 
photoreceptors (Collin and Oksche 1981; Oksche 1965). It is not surprising 
then that glutamate, which is a putative neurotransmitter in retinal 
photoreceptors (Copenhagen and Jahr 1989; Ulshafer et al. 1990), is found in 
high concentrations in pinealocytes. It has been recently demonstrated that 
glutamate, which is released from photoreceptors (Copenhagen and Jahr 1989) 
and activates second order neurons in the retina, can also influence 
photoreceptors directly by binding to an autoreceptor and depolarizing the cell 
(Sarantis et al. 1988; Tachibana and Kaneko 1988). 
A role for glutamate in the mammalian pineal gland is suggested by 
evidence for a specific binding site for this amino acid. Using [3H]glutamate 
as a ligand, a single, saturable and stereospecific binding site has been 
characterized in both bovine and rat pineal gland (Govitrapong et al. 1986; 
Kus et al. 1990). Although the precise function of this binding site has yet to 
be elucidated, there is evidence that glutamate modulates the adrenergic 
activation of melatonin synthesis and secretion in an in vitro system 
(Govitrapong and Ebadi 1988; Kus et al. 1991). 
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Because the mammalian pineal gland synthesizes and secretes 
melatonin in highest concentrations at night in vivo, the presence of 
compounds that modulate this process in vivo might also be expected to 
possess a similar 24 hour rhythm in the gland. The question of a circadian 
rhythm in glutamate concentration in the pineal gland was examined by 
measuring glutamate concentration in the gland over the 24 hour light-dark 
cycle. It was observed that glutamate levels do not change over the 24 hour 
light-dark cycle, a finding that can be interpreted several ways. It is possible 
that glutamate may be released from sympathetic nerve terminals in the 
gland in a tonic manner. Changes in the glutamate concentration over the 24 
hour light-dark cycle would therefore not be evident. It is also possible that 
glutamate may be released in very small quantities. Because nerve terminals 
make up such a small percentage of total pineal gland area, even concentrated 
amounts of glutamate released by nerve terminals may not be detected within 
the total pool of glutamate of approximately 2000 ng/gland. NE, for example, 
only increases from 2.3 ng/gland during the day to 4.7 ng/gland at night (Craft 
et al. 1984). In addition, glutamate is involved in general metabolism and if 
released from nerve terminals may not remain as free glutamate within the 
tissue for a long period of time. It may be immediately shunted by the cells 
into some other metabolic process such as protein or glutathione synthesis. It 
is also possible that glutamate is removed from the cell by its uptake carrier 
because it has been shown that even highly concentrating uptake systems can 
transport amino acids out of a cell (Van Winkle 1988). 
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An alternative explanation for the lack of a 24 hour rhythm in the 
glutamate content of pineal gland is that glutamate is not released from-
sympathetic nerve terminals, which are responsible for the cyclic release of 
NE in the gland. This is supported by the fact that immunocytochemical 
localization of glutamate does not show this amino acid to be highly 
concentrated within nerve terminals. It is interesting to note, however, that 
removal of sympathetic nerve terminals by means of sympathectomy, results 
in a significant decrease in the amount of glutamate present (48%) within the 
gland. This might be expected if the SCG is the source of "transmitter" 
glutamate. The effect of sympathectomy, however, was not specific for 
glutamate as alanine, aspartate, arginine and serine were also decreased, 
although to a lesser extent (16-36%). 
In view of the fact that amino acids are an essential component of 
intermediary metabolism, an effect of denervation on their content within 
the pineal gland was not unexpected. Sympathectomy, for example, is known 
to inactivate the indole biosynthetic pathway. Although it is unlikely that 
almost half the steady state levels of glutamate is required for cellular 
mechanisms leading to the synthesis and secretion of melatonin, it is difficult 
to say with much certainty that the loss of pineal gland glutamate after 
sympathectomy is due to loss of a transmitter pool located within sympathetic 
nerve terminals. It is possible that uptake of these amino acids, which in the 
case of glutamate occurs against a concentration gradient, is somehow 
inhibited by sympathetic denervation. It is known, for example, that the 
movement of one glutamate and three Na+ into the cell, while one K+ exits 
the cell requires the maintenance of the Na+ /K+ concentration gradient 
(Barbour et al. 1988; Brew and Attwell 1987). The observation that NE 
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stimulates Na+ /K+- ATPase activity in rat brain in vivo (Swann and Steketee 
1989) suggests that inhibition of the Na+ /K+ pump by denervation could affect 
amino acid uptake. 
The present data suggest that the decline in pineal glutamate was not 
related to a general effect of denervation on pineal metabolism because 
several other amino acids (glutamine, taurine, serine) were either unaffected 
or marginally decreased following sympathectomy. Soluble protein content 
was also unchanged after denervation, which is in good agreement with the 
findings of Moore and Rapport (1971) that ganglionectomy had no effect on 
pineal protein after 30 days. 
Glutamine, another important amino acid in intermediary 
metabolism, is believed to be in dynamic equilibrium with glutamate in 
nervous tissue where glutamine is partitioned principally within glia. Our 
immunocytochemical data suggest that a similar glial partitioning of 
glutamine exists in the pineal gland. Compartmentilzation of glutamate and 
glutamine is believed to be an important mechanism for separating metabolic 
regulation of these amino acids in neural functions (Nicklas et al. 1987). The 
present observation that pineal glutamine levels were not affected by 
denervation suggests that the effects of sympathectomy are specific and 
confined primarily to pinealocytes. The subcellular localization of glutamate 
within pinealocytes is similar to that seen in neurons (Torp et al. 1991). 
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Fig. 1. Alanine content of rat pineal gland over the 24 hour 
light-dark cycle. Alanine values expressed as mean± SEM 
are significant higher at 0+7 compared to other time points 
(p<0.05 Bonferroni). Control and sham operated groups did 
not differ significantly (p<0.77 ANOV A) and were combined. 
n = 12 pineal glands per group per time point. Ganglionectomy 
significantly decreased alanine level compared to control and 
sham values (p<0.01 ANOV A). n = 6 pineal glands per group 
per time point. 
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Fig. 2. Glutamate content of rat pineal gland over the 24 
hour light-dark cycle. Glutamate levels are expressed as 
mean + SEM. Control and sham operated groups did not 
differ significantly (p<0.92 ANOV A) and were combined. 
n = 12 pineal glands per group per time point. There was 
no significant differences in glutamate concentrations over 
the light-dark cycle (p<0.09). Ganglionectomy significantly 
decreased glutamate levels compared to control and sham 
operated values (p<0.01 ANOVA). n = 6 pineal glands per 
group per time point. 
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Fig. 3. Glutamine content of rat pineal gland over the 24 
hour light-dark cycle. Glutamine levels are expressed as 
mean± SEM. Control and sham operated groups did not 
differ significantly from one another and were combined. 
n = 12 pineal glands per group per time. Ganglionectomy 
did not effect glutamine content of the pineal gland. n = 6 
pineal glands per group per time point. 
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Fig. 4. Electron micrograph of pineal gland immuno-reacted for 
glutamate illustrating parts of pinealocytes (P), a glial process (G), 
noradrenergic neural elements (N) and endothelium (E). The 
density of gold particles tends to be greatest over the pinealocytes. 
Bar indicates 1.0 µM 
• 
Fig. 5. Electron micrograph of pineal gland immuno-reacted for 
glutamine. Glia (G) are intensely labelled, and there is sparse labelling 
over the neural element (N) in the perivascular space. P= pinealocyte 
L = lipid droplet. Bar indicates 1.0 µM 
55 
N 
6 
::t 
..._ 
r.fj 
QJ 
,-.c 
u 
•""4 
t 
~ 
~ 
"O 
,-.c 
0 
c., 
=#: 
50 
r.a Pinealocyte 
40 El Glia • Endothelium • Nerves 
30 • Background 
20 
10 
Glutamate Glutamine 
Fig. 6. Means + SEM of density of gold particles 
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compartment. n = 4 pineal glands. 
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-reacted for glutamate. Cytoplasm includes cytosol and 
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specifically sampled. n = 4 pineal glands. 
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Table 1. This table compares amino acid content of pineal glands obtained 
from control (C) and sham operated (S) animals. Means + SEM of amino 
acids (ng/gland) in the rat pineal gland over the 24 hour light-dark cycle are 
presented. Time is designated as hours after lights on (L) and hours after 
lights off (D). n = 6 pineal glands for each group at each time point. P values 
are based on F statistic for effect of treatment from a two-way ANOV A. A p< 
0.05 was considered significant. Control and sham operated values do not 
differ significantly in any of the amino acids. Control and sham values were 
therefore grouped in later statistical analysis (See Tables 2 and 3). 
L+l L+S L+9 0+3 0+7 0+11 Treat 
p>F 
Arg C 359±60 532 ±126 601±124 623±89 549±99 489±61 
s 548±55 498±116 711±95 551±80 677±86 480±88 0.09 
Asp C 434±94 388±47 499±95 401±60 396±88 293±56 
s 565±70 479±110 473±85 446±132 397±102 215±35 0.53 
Ala C 178±22 200±14 241±40 189±33 284±33 268±26 
s 228±21 182±21 206±25 199±35 313±40 204±28 0.77 
Glu C 1713±243 2105±191 2305±303 2008±211 1886±314 1790±156 
s 2448±150 1873±255 2342±243 1765±296 1949±187 1472+283 0.92 
Gln C 1010±149 1226±134 1323±198 1350±150 1268±148 1095±29 
s 1289±90 1034±141 1335±104 1140±158 1189±130 955±166 0.47 
Ser C 471±109 412±41 651±185 371±22 474±66 534±76 
s 411±56 398±44 484±127 408±63 397±121 320±46 0.09 
Tau C 1587±211 2014±111 2156±379 1966±216 1356±103 1974±171 
s 2279±217 1886±243 2670±408 1800±341 2005±320 1846±293 0.08 
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Table 2. This table examines amino acid content of pineal glands over time. 
Control and sham operated groups are combined as C/S. Values are 
presented as means + SEM of amino acids (ng/ gland). Time is designated as 
hours after lights on (L) and hours after lights off (D). P values are based on F 
statistic for effect of time from one-way ANOVA. A p< 0.05 was considered 
significant. Significant differences over time are seen only in alanine in the 
C/S group. No differences over time in amino acid content was seen in any 
ganglionectomized (G) group. n = 12 (C/S) or 6 (G) pineal glands for each 
group at each time point. 
L+l L+S L+9 0+3 0+7 0+11 Time 
p>F 
Arg C/S 454±48 515±78 656±73 587±56 613±63 485±47 0.13 
G 317±46 339±58 317±34 326±24 377±69 429±98 0.67 
Asp C/S 499±57 433±56 486±58 423±67 396±61 257±34 0.05 
G 251±51 284±50 247±66 333±64 290±49 283±21 0.82 
Ala C/S 203±16 191±12 224±22 194±22 299±24 239±20 0.01 
G 145±22 118±10 163±29 147±24 151±26 182±23 0.54 
Glu C/S 2080±174 1989±149 2324±177 1886±170 1917±167 1646±147 0.09 
G 1005±214 851±98 1052±107 949±122 1068±171 1185±229 0.78 
Gln C/S 1150±91 1130±93 1329±101 1245±105 1228±90 1031±72 0.26 
G 1123±113 988±148 1098±92 1072±142 1264±182 1322±242 0.66 
Ser C/S 441±57 405±27 567±105 389±31 435±64 427±55 0.34 
G 356±35 326±69 449±109 355±36 317±25 441±42 0.56 
Tau C/S 1933±176 1950±123 2413±266 1883±185 1680±184 1916±146 0.11 
G 1910±322 1693±181 1815±144 1705±178 1776±246 2083±410 0.88 
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Table 3. This table compares amino acid content of pineal glands obtained 
from control and sham operated (combined as C/5) with ganglionectomized 
(G) animals. Means + SEM of amino acids (ng/ gland) in the rat pineal gland 
over the 24 hour light-dark cycle are presented. Time is designated as hours 
after lights on (L) and hours after lights off (D). n = 6 pineal glands for each 
group at each time point. P values are based on F statistic for effect of 
treatment from two-way ANOV A. A p< 0.05 was considered significant. 
Significant differences between control and sham (C/S) and 
ganglionectomized (G) groups were seen in arginine, aspartate, alanine and 
glutamate but not in glutamine and taurine. 
L+l L+S L+9 D+3 D+7 D+ll Treat 
p>F 
Arg C/S 454±48 515±78 656±73 587±56 613±63 485±47 
G 317±46 339±58 317±34 326±24 377±69 429±98 0.01 
Asp C/S 499±57 433±56 486±58 423±67 396±61 257±34 
G 251±51 284±50 247±66 333±64 290±49 283±21 0.01 
Ala C/S 203±16 191±12 224±22 194±22 299±24 239±20 
G 145±22 118±10 163±29 147±24 151±26 182±23 0.01 
Glu C!S 2080±174 1989±149 2324±177 1886±170 1917±167 1646±147 
G 1005±214 851±98 1052±107 949±122 1068±171 1185±229 0.01 
Gln C/S 1150±91 1130±93 1329±101 1245±105 1228±90 1031±72 
G 1123±113 988±148 1098±92 1072±142 1264±182 1322±242 0.66 
Ser C/S 441±57 405±27 567±105 389±31 435±64 427±55 
G 356±35 326±69 449±109 355±36 317±25 441±42 0.10 
Tau C/S 1933±176 1950±123 2413±266 1883±185 1680±184 1916±146 
G 1910±322 1693±181 1815±144 1705±178 1776±246 2083±410 0.34 
CHAPTER IV 
PINEAL GLAND AMINO ACIDS IN THE RAT II. 
CHARACTERIZATION OF A [3H]GLUTAMATE BINDING SITE 
Abstract 
Glutamate, an excitatory neurotransmitter/ neuromodulator involved 
in cell to cell communication within the central nervous system is now 
believed to play a role in neuroendocrine function. In this study we describe 
a single, saturable and stereospecific binding site for [3H]glutamate (Kci = 612 + 
23 nM, Bmax = 3170 + 330 fmol/mg protein). Binding of [3H]glutamate was 
temperature, time, and pH-dependent. After removal of the sympathetic 
innervation to the pineal gland, [3H]glutamate binding displayed a higher 
appparent affinity (Ki = 412 + 28 nM) (p<0.05 T-test) without a change in 
binding site number (Bmax = 3600 + 240 fmol/mg protein). No difference in 
[3H]glutamate binding site number was observed in pineal glands obtained 
from animals sacrificed during the middle of either the light or dark periods. 
These data suggest a possible modulatory role for glutamate in pineal gland 
function. 
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Introduction 
The excitatory amino acid (EAA) glutamate plays an important role in 
both normal and pathological brain function. Acting via its AMPA, kainate, 
and NMDA receptors, glutamate depolarizes postsynaptic neurons by opening 
ion channels and allowing the influx of Na+ and Ca2+ (Asher and Nowak 
1987; Hollmann et al. 1991). Glutamate also stimulates second messenger 
production by interacting with a fourth receptor subtype, the metabotropic 
receptor (Sladeczek et al. 1988). Activation of these receptors within the 
central nervous system is believed to mediate such diverse phenomena as 
learning (Lynch et al. 1990), visual plasticity (Dudek and Bear 1989), neuronal 
differentiation (Mattson et al. 1988) and possibly cell death (Choi and 
Rothman 1990). The recent observation that a majority of excitatory 
neurotransmission within the neuroendocrine mediobasal hypothalamus is 
mediated by glutamate (Van den Pol et al. 1990) also suggests that this amino 
acid may play an important role in the regulation of neuroendocrine systems. 
The pineal gland is an important component of the neuroendocrine 
system regulating circadian rhythmicity. The release of NE from post-
ganglionic sympathetic fibers originating in the superior cervical ganglion 
(SCG) stimulates the production of the pineal hormone melatonin via its 
binding to adrenergic receptors located on pinealocytes (Sugden 1989). The 
pineal gland also possesses a number of other receptor types, including those 
for benzadiazepine, dopamine, GABA and glutamate (Ebadi 1987). While the 
function of these latter receptors is unclear, a possible role for glutamate in 
pineal gland function of the rat has been suggested by several observations. 
First, glutamate is found in relatively high concentrations in the rat pineal 
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gland (McNulty et al. 1989). Second, glutamate has been demonstrated to 
inhibit NE stimulated serotonin SNAT activity in the rat pineal in vitro. 
(Govitrapong and Ebadi 1988). Due to the small amount of tissue present in 
the rat pineal, however, identification of a glutamate binding site in this 
species has not been made. Because the rat is an important animal model in 
pineal gland research, the goal of this study was to identify and characterize a 
glutamate binding site in the rat pineal gland with the use of in vitro 
quantitative receptor autoradiography. 
In addition, we have also examined several possible ways in which 
pineal glutamate binding sites can be regulated. With regard to the 
observation that steady state levels of glutamate can be markedly reduced by 
SCGx (McNulty et al. 1989), it was important to ascertain the effects of 
denervation on this binding site. Examination of [3H]glutamate binding after 
SCGx was also expected to yield additional information about the location of 
[3H]glutamate binding, i.e binding to pre- or post-synaptic sites. Finally, 
because NE content, 13-adrenergic receptor density, and melatonin levels 
exhibit significant differences over the light-dark cycle (Gonzalez-Brito and 
Reiter 1987), pineals were examined for day vs night differences in glutamate 
binding site number. 
Materials and Methods 
Chemicals 
[3H]Glutamate (SA= 43-56 Ci/mmol) was obtained from Amersham 
(Arlington Heights, IL). Quisqualate, CPP ((+/-) -3-(2-carboxypiperazin-4-yl)-
propyl-1-phosphonic acid), and CNQX (6-cyano-7-nitro-quinoxaline-2,3-dione) 
were obtained from Research Biochemicals Inc. (Natick, MA). All other 
compounds were obtained from Sigma Chemical Co. (St. Louis, MO). 
Animals 
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A total of 64 adult male Sprague-Dawley rats (Sasco-King, Oregon, WI) 
were used in this study. Animals were housed in a fully accredited animal 
care facility and were used according to the recommendations in the Guide 
for the Care and Use of Laboratory Animals and The Guidelines of the 
Institutional Animal Care and Use Committee at Loyola University Medical 
Center. All animals were entrained to a 12:12 hour light-dark cycle and had 
access to food and water ad libitum. Animals were sacrificed by rapid 
decapitation over the light:dark cycle at times specified in each experiment. A 
dim red light (Kodak filter 1A) was used for dark-time sampling. 
Superior Cervical Ganglionectomy Procedures 
For bilateral removal of the superior cervical ganglia (SCG), animals 
were anesthetized with pentobarbitol (65 mg/kg ip), placed in an aseptic 
surgical field, and a ventral midline incision made on the neck. The carotid 
sheath and contents were exposed and the sympathetic chains were followed 
rostrally to the superior cervical ganglia. The ganglia were removed with fine 
forceps and micro-scissors and the incision closed with sterile silk suture. A 4 
week recovery period was allowed. 
Autoradiography 
Following sacrifice, pineal glands were rapidly removed and frozen on 
dry ice. Tissue was subsequently placed in embedding matrix for support and 
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sectioned with a Leitz (Model II) cryostat at a thickness of 10-14 µm. Sections 
(3-4) were placed on the ends of individual gel coated slides and frozen at -
700c overnight. A single pineal yielded 50-60 sections, enough for a complete 
saturation or competition curve. The tissue was preincubated in 0.05M Tris 
acetate buffer, pH 7.2 at 4°C for 20 min. Sections were dried with a stream of 
cool air and incubated at 4°C for 60 min in Tris buffer with increasing 
concentrations of L-[3H]glutamate (further referred to as [3H]glutamate) (25 
nM-800 nM). Non-specific binding was determined by addition of 1000 fold 
excess non-radioactive glutamate and was subtracted from total binding to 
determine specific binding. Competition assays to determine receptor 
subtypes utilized a single concentration of [3H]glutamate (200 nM) and 
increasing concentrations of various non-radioactive compounds (25 nM-200 
mM). To terminate the binding reaction, sections were rinsed in ice cold Tris 
acetate buffer for 2 minutes with 1 buffer change. Sections were rapidly dried 
under cool air and placed in X-ray cassettes with appropriate radioactive 
standards (Microscales, Amersham). Tissue was apposed to tritium sensitive 
Hyperfilm (Amersham) for 3-6 weeks at 4°C. The film was developed in fresh 
Kodak D19 for 5 minutes, fixed, rinsed and dried. Autoradiograms were 
analyzed by computer assisted microdensitometry (RAS 5000 system, 
Amersham). Bound radioactivity was determined by a computer generated 
polynomial regression analysis which compares film densities produced by 
pineal sections with those produced by tritium standards. Saturation data 
were analysed according to the method of Scatchard (Scatchard 1949). Ki 
values were calculated from ICso values using the equation of Cheng and 
Prusoff: Ki = ICso/ (1 + [3H-Glu] / Ki) (1973). 
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fila tis tics 
Statistical analysis of the data was performed with the Student's t-test. 
Results 
Binding Assays 
[3 H]Glutamate binding in intact animals 
Saturation analysis of [3H]glutamate binding revealed a single binding 
site with a Hill coefficient= 0.932 ± 0.028 (Fig. 2), an apparent dissociation 
constant (Kd) of 612 ± 23 nM and a Bmax of 3170 + 330 fmol/mg protein (Fig. 
1). Binding was time, temperature, and pH dependent with optimal 
conditions at 60 minutes (Fig. 3), 4°C (Fig. 4), and pH 7.2 (Fig. 5). Various 
glutamate agonists and antagonists demonstrated a range of competition for 
bound [3H]glutamate. L-Glutamate was the best competitor with a Ki value of 
536 + 37 nM (Fig. 6), while the D-isomer was inactive. Quisqualate displayed 
moderate inhibition of binding with a Ki value of 34000 + 5500 nM (Fig. 7). 
All other compounds tested were inactive (Table 1). 
Mid-light vs mid-dark [3 H]glutamate binding 
Specific [3H]glutamate binding in the pineal gland of animals entrained 
to a 12:12 hour light-dark cycle and sacrificed during the middle of the dark 
period did not differ significantly from binding observed in pineals obtained 
from animals sacrificed during the middle of the light period (Fig. 8). 
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[3 H]Glutamate binding in SCGx animals 
SCGx was confirmed in all animals by the presence of ptosis bilaterally. 
Saturation analysis of [3H]glutamate binding in this group demonstrated a 
single binding site with a Hill coefficient of 0.987 + 0.021, a KcI of 412 + 28 nM 
and a Bmax of 3600 + 240 fmol/mg protein. Sympathectomized pineal glands, 
when compared to intact controls, possessed a higher apparent affinity for 
[3H]glutamate binding (p<0.05) without a change in binding site number (Fig. 
9). 
Discussion 
In this paper, we describe a single, saturable, stereospecific, 
temperature, time, and pH-dependent binding site for glutamate in the pineal 
gland of the rat which has not been previously characterized. Our values are 
consistent with values reported by other investigators for glutamate binding 
in other brain regions (Cincotta et al. 1989; Fagg et al. 1983) as well as in the 
bovine pineal (Govitrapong et al. 1986). Interestingly, the only compound 
that demonstrated a relatively high affinity for [3H]glutamate binding was L-
glutamate itself. While quisqualate inhibited [3H]glutamate binding, the high 
Ki value of 34000 + 5500 nM (relative to that observed for quisqualate 
inhibtion in other brain regions), suggests that it is unlikely that this 
corresponds to the functional quisqualate/ AMPA receptor described in other 
brain regions. Contamination of quisqualate by L-glutamate is believed to be, 
in part, responsible for this low affinity component of quisqualate binding 
(Cha et al. 1989). 
68 
It should be noted that the binding of [3H]glutamate in tissue can 
represent binding to several membrane components, including receptors 
linked to ion channels/second messenger systems, uptake sites, and enzymes. 
In addition, sequestration of ligand by lipid vesicles within tissue can occur. 
To minimize the possibility of [3H]glutamate uptake, the present saturation 
and competition studies were performed in sodium, chloride, and calcium-
free buffer. No inhibition of [3H]glutamate binding was observed in the 
presence of D-aspartate, an amino acid with relatively high affinity for the 
Na2+-dependent glutamate uptake site. The possibility that [3H]glutamate 
may have bound to an enzyme similiar to the one responsible for the 
cleavage of the endogenous peptide N-acetyl-aspartyl-glutamate (Slusher et al. 
1990; Stauch et al. 1989) is not likely for several reasons. First, as outlined by 
Slusher et al. (1990) and Stauch et al. (1989), this enzyme, N-acetylated-alpha-
linked acid peptidase (NAALA dipeptidase), has been demonstrated to have a 
much higher affinity for quisqualate than L-glutamate. We have observed 
the opposite rank order for these 2 compounds in the pineal gland. Second, 
NAALA dipeptidase appears to have an absolute requirement for chloride for 
its activation and we did not include chloride in our incubation buffer. 
Third, binding of [3H]glutamate in this study was greater at 4°C than at 37°C, 
not a common feature of enzyme-substrate interactions. While the type of 
glutamate binding site present in the rat pineal gland is not clear, it does not 
appear to be one of the major glutamate receptor subtypes (AMPA, kainate, or 
NMDA) as even high concentrations of competitor did not inhibit 
[3H]glutamate binding. It is possible that this binding site is similar to the 
Na2+ and Cl--independent glutamate binding site described in the 
neurohypothysis (Yoneda and Ogita 1989). Glutamate binding at this site 
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possesses a Kd = 340 nM and is sensitive to inhibition by quisqualate OCso = 
56µM) but not other glutamate analogues. Dissimilarities, however, indude 
the fact that binding site number increase if the tissue is incubated at 30°C 
when compared to 2°C. Functional studies to examine the role of glutamate 
on the adrenergic stimulated production of melatonin may help to elucidate 
the role of glutamate in pineal gland function. 
The observed increase in the affinity of [3H]glutamate binding after 
SCGx without a corresponding change in receptor number may have been 
due, in part, to a decrease in the amounts of endogenous ligand present after 
SCGx. The intact pineal gland of the rat possesses relatively high levels of 
glutamate that decrease by approximately 50% after SCGx (McNulty et al. 
1989). It is possible that tissue preincubation may not have removed all the 
free glutamate present within the tissue sections, thereby decreasing the 
apparent affinity of [3H]glutamate binding in intact glands without altering 
binding site number. A similar problem with contamination by L-glutamate 
was noted in homogenous preparations of retinal membranes (Yoneda and 
Ogita 1989). 
Based on the observation that glutamate stimulates the release of 
[3H]NE from synaptosomes prepared from hippocampus, olfactory bulb, and 
cerebral cortex, it is believe that presynaptic receptor for glutamate are present 
on noradrenergic terminals (Wang et al. 1992). The observation that receptor 
number did not change after SCGx suggests that binding sites for 
[3H]glutamate were located either on pinealocytes and/or astrocytes and not 
on noradrenergic nerve terminals. 
Unlike noradrenergic receptors (Pangerl et al. 1990), a day-night 
difference in [3H]glutamate binding site number was not observed. In 
addition, the observation that glutamate levels in the pineal gland do not 
vary over the light-dark cycle (McNulty et al. 1989) suggests that the role of 
these binding sites may be tonic in nature. Previous demonstration of 
glutamate's ability to inhibit the NE-induced production of inositol 
phospholipids in various brain regions (Jope and Li 1989) suggests a 
mechanism by which glutamate may interact with the adrenergic system to 
inhibit melatonin production. 
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Fig. 1. Saturation and Scatchard analysis of [3H]glutamate binding in rat 
pineal glands. These studies, performed in c1-, Na+, and Ca2+ free buffer, 
utilized ligand concentrations between 25 nM and 800 nM. Non-specific 
binding was determined by the addition of 1000 fold excess inert 
glutamate. Each pineal gland provided a complete saturation curve. Six 
pineal glands were analysed. Binding at each concentration of 
[3H]glutamate was performed in triplicate. Ka= 612 + 23 nM, Bmax = 
3170 + 330 fmol/mg protein. 
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Fig. 2. Representative Hill plot of [3H]glutamate saturation binding 
data from rat pineal glands. Hill coefficient = slope of line. 
Equation of representative line is y = -2.630 + 0.995x. Hill coefficients 
obtained from six saturation curves (six pineal glands) yield a 
mean± SEM of 0.932 ± 0.028. These data suggests a single 
[3H]glutamate binding site. 
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Fig. 3. Specific [3H]glutamate binding (288nM, SA= 43 Ci/ 
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Fig. 6. Inhibition of [3H]glutamate binding (218nM, SA= 
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n = 5 pineal glands. 
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were detected. 
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Fig. 9. Representative Scatchard graphs comparing [3H]glutamate binding 
in pineal glands from intact and ganglionectomized animals (6 animal = 6 
Scatchard graphs/ group). Denervated glands (squares) possess a 
significantly higher apparent affinity (Kd= 412 + 28 nM) p<0.002 for L-
[3H]glutamate binding than intact glands (circles) (Kd=612 ± 23 nM). 
Receptor number (Bmax) did not change with ganglionectomy (3600 ± 240 
vs 3170 ± 330 fmol/mg protein - gangX vs control, respectively). 
Table 1. Inhibition of [3H]glutamate binding (100 - 300 nM) in rat pineal 
gland by various non-radioactive compounds. Data represent the means 
± SEM of 3 - 5 inhibition curves (1 pineal gland/ curve). Ki values were 
calculated from ICso values using the equation of Cheng and Prusoff (1973). 
Number of pineal glands are shown in parenthesis. 
Ki (nM) 
L-Glutamate (5) 535 + 37 
D-Glutamate (3) >200000 
Quisqualate (3) 34000±550 
CNQX (5) >200000 
N-Methyl-D-Aspartate (4) >200000 
CPP (4) >200000 
Kainate (4) >200000 
D-Aspartate (4) >200000 
APB (3) >100000 
Taurine (3) >200000 
Melatonin (3) >200000 
Norepinephrine (3) >200 
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CHAPTER V 
GLUT AMA TE INHIBITION OF THE ADRENERGIC-STIMULATION 
SECRETION OF MELATONIN IN THE RAT 
PINEAL GLAND IN VITRO 
Abstract 
The effect of L-glutamate on the adrenergic stimulated release of 
melatonin in the rat pineal gland was examined using an in vitro perifusion 
system. L-Glutamate by itself had no effect on melatonin production while L-
glutamate administered prior to (-)isoproterenol (~-adrenergic agonist) and L-
phenylephrine (a-adrenergic agonist) inhibited melatonin production by 42 
%. L-Glutamate did not inhibit melatonin production when glands were 
stimulated with (-)isoproterenol alone. D-glutamate as well as the L-
glutamate agonists, kainate, NMDA, quisqualate and trans-ACPD had no 
effect on melatonin release. The possibility that L-glutamate may be 
converted to another neuroactive compound (GABA) prior to the addition of 
(-)isoproterenol and L-phenylephrine is suggested by the observation that 
simultaneous administration of L-glutamate with (-)isoproterenol and L-
phenylephrine did not inhibit melatonin secretion. 
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Introduction 
In the pineal gland of every mammalian species studied, the 
autonomic nervous system plays a pivotal role in regulating the production 
of the pineal hormone melatonin (Kappers 1965). NE released from the 
postganglionic neurons of the SCG activates the rate limiting enzyme in 
melatonin synthesis, SNAT, via its binding to a- and P-adrenergic receptors 
(Klein et al. 1987). A number of other receptor types have been described in 
the pineal gland including D2-dopaminergic, GABAergic, glutaminergic and 
cholinergic, the functions of which are presently unknown (Ebadi et al. 1986). 
The characterization of a binding site for L-[3H]glutamate in the pineal gland 
of the rat (Kus et al. 1990) together with the observation that high amounts of 
glutamate are normally present in the gland (Govitrapong and Ebadi 1988; See 
Chapter IV) prompted the present investigation of the function of this 
binding site. 
Known to act as an excitatory neurotransmitter in most regions of the 
central nervous system, glutamate has been reported to inhibit SNAT activity 
in the pineal gland of the rat in vitro (Govitrapong and Ebadi 1988). 
Inhibitory effects of glutamate are, however, rare (Mayer and Westbrook 
1987). Accordingly, we examined the role of glutamate in pineal gland 
function by testing the effects of various glutamate agonists on the adrenergic 
stimulated secretion of melatonin in vitro. 
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Materials and Methods 
Chemicals 
Quisqualate was obtained from Research Biochemicals Inc. (Natick, MA). 
Trans-ACPD was a gift from D. Monaghan (Omaha, NE). All other compounds 
were purchased from Sigma (St. Louis, MO). 
Animals 
A total of 58 adult (2 - 4 months) male Sprague-Dawley rats (Sasco-King, 
Oregon, WI) were used in this study. Animals were housed in a fully accredited 
animal care facility and were used according to the recommendations in the Guide 
for the Care and Use of Laboratory Animals and The Guidelines of the Institutional 
Animal Care and Use Committee at Loyola University Medical Center. All 
animals were entrained to a 12:12 hour light-dark cycle (1000 lux). For all 
experiments, animals had access to food and water ad libitum. Animals were 
sacrificed by rapid decapitation during the middle of the light cycle. 
Perifusion 
All experiments were performed using an Acusyst-S-APS 10 
programmable flow through perifusion sysytem (Endotronics, Coon Rapids, 
MN). Glands were rapidly dissected and placed in ice cold oxygenated (95% 
02, 5% CO2) artificial cerebral spinal fluid (CSF) (pH 7.3) during the sampling 
period. Tissue was then transferred to the perifusion chamber (4X10 mm) 
where prewarmed (37°C), oxygenated artificial CSF was delivered at a rate of 
0.208 ml/minute or 0.037 ml/minute in experiments where LDH was assayed. 
One pineal gland was placed in each chamber. Pineal glands were 
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equilibrated by preincubation for a period of 4 hours at which time melatonin 
output reached basal levels. Tissue was incubated in either the presence of (-
)isoproterenol (Iso) (10-5M-10-6M) and L-phenylephrine (PE) (10-5M-10-6M) or 
L-glutamate alone (JO-3M) In experiments that examined the effect of 
glutamate agonists on the Iso and PE-stimulated secretion of melatonin from 
pineal glands, the following paradigms were used: L-Glutamate (5 X 10-6M - 5 
X 10-3M) or D-glutamate (JO-3M) were administered to glands 4 hours after 
the start of the experiment (4.0 hr) for 60 minutes followed by Iso (10-6M) and 
PE (10-6M) at 5.0 hr for 25 minutes. Glutamate agonists, kainate, NMDA, and 
guisqualate (10-4M), were administered to glands at 4.5 hour for 30 minutes 
folowed by Iso (10-6M) and PE (10-6M) at 5.0 hr for 25 minutes. Trans-ACPD 
(10-4M) was administered to glands at 4.0 hour for 30 minutes folowed by Iso 
(10-6M) and PE (10-6M) at 5.0 hr for 25 minutes. D,L-APB (2 X 10-4M) was 
administered to glands at 4.5 hour for 30 minutes folowed by Iso (10-6M) and 
PE (10-6M) at 5.0 hr for 25 minutes. Mg2+ was omitted and glycine (10-6M) was 
added to the buffer when experiments included NMDA because Mg2+ inhibits 
and glycine potentiates the action of NMDA at its receptor. Samples of 
perfusate were collected every 30 minutes by a fraction collector and stored at 
4°C until assayed for melatonin content. 
Radioimmunoassay 
Artificial CSF obtained from in vitro perifusion studies was assayed for 
melatonin with the use of a direct radioimmunoassay based on a modified 
method of Fraser (Fraser et al. 1983 ). Briefly, samples (100µ1) were 
incubated with antiserum (sheep antiserum 704-8483, diluted 1:30,000, 
Guildhay, U.K.) and labeled ([3H] melatonin 81.1 Ci/mmol) overnight at 40c 
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in tricine buffered saline (TBS) with 0.1 % gelatin (pH 5.5). Bound and free 
melatonin were separated by the addition of a dextran coated charcoal 
solution (2.5 g charcoal, 0.25 g dextran/1 TBS) to samples. Samples were 
centrifuged at 1500 X G for 15 minutes and the supernatant decanted into 
scintillation vials. Bound radioactivity was counted in a Packard tri-carb beta 
scintillation counter. Unknown sample values were calculated from a 
standard curve constructed from known amounts of melatonin (0 -100 pg). 
Lower limit of sensitivity was 2.0 - 3.0 pg/tube. Intra-assay and inter-assay 
coefficients of variability were 8.0% and 15% respectively. 
High Performance Liquid Chromatography (HPLC) of Amino Acids 
General methods for HPLC have been described elsewhere (McNulty et 
al. 1987; McNulty et al. 1990). Briefly, pineal glands were quickly dissected, 
frozen on dry ice, and stored at -70°C until assayed. Glands were 
homogenized in cold 0.05 M monobasic phosphate buffer (pH 7.0). 
Homogenates were centrifuged at 15,000X g for 2 mins and aliquots of 
supernatant were injected directly into the chromatographic system 
consisting of a Rainin Rabbit pump, a Rheodyne 7125 inject port with a 100 µl 
sample loop, and a C18 reverse phase column (10 cm X 4.6 cm, 3 mm particle 
size, Rainin Instruments, Woburn, MA). Levels of free amino acids were 
determined using pre-column derivatization with o-phthaldialdehyde (OPA; 
Sigma) as described previously (McNulty et al. 1990). Fluorescence emitted by 
the derivatized compounds was measured with a LDC Fluoromonitor III 
(Milton Roy, Riviera Beach, FL) equipped with standard excitation (340-380 
nm) and emission (418-700 nm) filters. The detector was connected to a HP 
3390A integrator (Hewlett Packard, Avondale, PA) used to analyze the peaks. 
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The mobil phase consisted of 0.1 M monobasic sodium phosphate mixed with 
HPLC-grade methanol (32%) and delivered at a rate of 1.0 ml/min. 
Identification of eluted compounds were based on retention times, and the 
concentration of samples were determined by comparison with synthetic 
standards made daily from stock solutions. Aliquots of supernatant were 
reserved for the measurement of soluble proteins according to the method of 
Lowry et al. (1951). 
Lactate Dehydrogenase (LDH) Assay 
Secretion of LDH, an intracellular enzyme, was measured as an 
indicator of cell damage or death using a colorimetric kit (Sigma). LDH in the 
buffer catalyzed the following reaction: pyruvic acid+ NADH, lactic acid+ 
NAD. Unconverted pyruvic acid, when treated with 2,4-
dinitrophenylhydrazine, produces a phenylhydrazone that is highly colored. 
LDH activity is inversely proportional to the absorbance of the color formed. 
Absorbance was measured at a wavelength of 464 nm. 
Statistics 
All data points are presented as mean+ SEM. Data obtained from 
experiments comparing melatonin and LDH release from control and 
experimental pineal glands over time were analysed with a two-way ANOV A 
with repeated measures. Total melatonin secreted from each gland 4.5 hours 
to termination of experiment was calculated and means of control and 
experimental glands were compared with a Student's T-test. Differences in 
amino acid content of control and experimental pineal glands were analyzed 
with a Student's T-test. 
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Results 
Stimulation of pineal glands by adrenergic agonists 
Spontaneous release of pineal gland melatonin reached baseline (10-20 
pg/min/gland) by 4 hours after the start of the experiment (Fig. 1). At this 
time most drug admininstration was initiated. A similar time course for the 
decrease in spontaneous melatonin release has been previously reported 
(Simonneaux et al. 1989). This unstimulated release of melatonin from the 
gland was most likely due to cell damage caused by removal of the gland from 
the brain. LDH release, an indicator of cell damage, had a pattern similar to 
spontaneous release of melatonin shown in Fig. 2. Differences in the initial 
release of melatonin by pineal glands between experiments may be due to 
differences in sampling time, i.e the amount of time glands remained in cold 
buffer before being transferred to the perifusion apparatus. Pineal glands 
were stimulated by lso and PE in a dose dependent manner (10-6 - 10-SM) with 
a detectable increase in melatonin secretion approximately 1.5 hours after Iso 
and PE administration (Fig. 3). Addition of PE (10-6M) to pineal glands did 
not potentiate the 13-adrenergic-induced (Iso (10-6M) and prazosin (10-6M)) 
response (Fig. 4). 
Effect of L-glutamate on melatonin production 
L-Glutamate (10-3M) by itself neither stimulated the secretion of 
melatonin nor significantly altered baseline levels (Fig. 5). L-Glutamate (l0-3 
M) administered before lso (10-6M) and PE (10-6M) significantly inhibited 
melatonin secretion (p<0.025 ANOVA), decreasing hormone concentrations 
by approximately 42% (Fig 6). Lower doses of L-glutamate (5 X 10-6 Mand 5 X 
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10-4 M) (Figs. 7, 8) had no attenuating effect. A higher dose of glutamate (5 X 
10-3M (Fig. 9) did not significantly decrease melatonin secretion (p<0.065 
ANOVA). D-glutamate (10-3M) was ineffective (Fig. 10). 
Melatonin production stimulated by lso (10-6M) alone was not 
inhibited by 1 hour pretreatment with L-glutamate (1Q-3M) (Fig 11). To assure 
that the alpha-1 receptor was not activated during these experiments, 
prazosin (10-6M), an a.1 antagonist was added to the artificial CSF. To rule out 
any stimulatory effects of prazosin, the experiment was repeated, but without 
the addition of prazosin (Fig. 12). L-Glutamate (1Q-3M), again, did not inhibit 
the Iso (10-6M) stimulated secretion of melatonin. 
Effect of L-glutamate agonists on melatonin secretion 
Agonists of the four major glutamate receptor subtypes were assayed 
for their ability to inhibit Iso (10-6M) and PE (10-6M) stimulated production of 
melatonin. NMDA, kainate, quisqualate (100µM) (AMPA and metabotropic 
receptors), D,L-APB (200µM) and trans-ACPD (100µM) (metabotropic receptor) 
were all ineffective at attenuating the melatonin secretion stimulated by Iso 
and PE (Figs. 13 -17). 
Timing of L-glutamate administration 
L-glutamate administered 2 hour before Iso and PE did not significantly 
decreased melatonin secretion (p<0.42 ANOVA) (Fig. 18). Simultaneous 
administration of L-glutamate and Iso and PE at 4.0 hour for 25 minutes did 
not inhibit melatonin secretion (Fig. 19). 
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Amino acid content of pineal glands administered L-glutamate 
The only amino acid found to increase significantly in pineal glands 
administered L-glutamate (IQ-3M) was L-glutamate itself, (p<0.02 T-test) (Fig 
20). Glutamine levels in the tissue were somewhat higher(~ 27%) although 
not statistically significant. 
Discussion 
The importance of glutamate as a neurotransmitter within the central 
nervous system has been clearly established (Mayer and Westbrook 1987). 
Only recently gaining recognition as a modulator of neuroendocrine function 
in the mediobasal hypothalamus (Van den Pol et al. 1990), L-glutamate has 
also been reported to stimulate the release of prolactin from pituitary glands 
(Login 1990) and the release of catecholamines from isolated adrenal medulla 
(Nishikawa et al. 1982). L-Glutamate in this study, while having no effect by 
itself, inhibited melatonin production in adrenergically stimulated pineal 
glands. From an earlier study by Govitrapong and Ebadi (1988) demonstrating 
that glutamate inhibits NE-induced SNAT activity it appears that inhibition 
of melatonin production by glutamate is most likely due to mechanisms 
involving the SNAT enzyme. The present study extends the observations of 
Govitrapong and Ebadi (1988) by demonstrating that inhibition of glutamate 
occurs only if both ~-and a-adrenergic receptors are stimulated. If the~-
adrenergic receptor is stimulated alone, no inhibition occurs. This suggests 
an important role for the a-adrenergic receptor in the glutamate induced 
inhibition of melatonin synthesis. 
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Because inhibitory effects of glutamate are rare, the possibility that cell 
death contributed to the decrease in melatonin release was considered. 
Glutamate-induced toxicity as seen in neurons is very complicated, involves 
many steps and is not fully understood (Choi and Rothman 1990). When 
cells are over stimulated by glutamate, i.e. too much is released or it is not 
removed from the extracellular space, cells begin to swell as an excess amount 
of sodium enters. This is followed by c1- and water and leads to osmotic lysis 
of the cells (Olney et al. 1986). Glutamate, via the NMDA receptor, can also 
stimulate excess Ca2+ influx into cells. An increase in intracellular Ca2+ 
activates many enzymes including phospholipase A2 which leads to an 
increase in arachidonic acid (Choi and Rothman 1990). Arachidonic acid can 
lead to an increase in free radical formation via the enzymes lipoxygenase 
and cyclooxygenase. Because activation of the a.-adrenergic receptor 
stimulates arachidonic acid formation in the pineal gland, it might be 
hypothesized that glutamate acting at its pineal binding site synergizes with 
the a.-adrenergic receptor to produce toxic levels of this compound. Studies 
designed to measure levels of arachidonic acid in glands treated with 
glutamate and Iso and PE would test this hypothesis. 
Another mechanism by which the Iso- and PE-induced production of 
melatonin may be inhibited by glutamate may be through depolarization of 
the pinealocyte membrane. It has been demonstrated that agents that cause 
depolarization of the pinealocyte membrane, e.g. oubain and K+, lead to an 
inhibition of the NE-induced membrane hyperpolarization as well as to an 
inhibition of SNAT activity (Parfitt et al. 1975). Interestingly, a decrease in 
cAMP formation was not noted in these experiments. In another study in 
which the effects of a.MSH on pineal gland function were examined, it was 
noted that depolarization of the membrane by exMSH inhibits the ability of 
NE to stimulate cAMP formation (Sakai et al. 1976). The mechanism by• 
which membrane depolarization inhibits cAMP or SNAT activity is not 
known. 
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In addition to the two possible aforementioned mechanisms of 
glutamate inhibition of melatonin secretion, another possible mechanism 
should be considered. While it has been well documented that activation of 
the exl-adrenergic receptor can potentiate the P-adrenergic induced production 
of cAMP (Klein et al. 1987), it has been recently been demonstrated that 
exclusive activation of the ex isoform of PKC leads to the inhibition of cAMP 
formation. The isoforms identified in the pineal gland are the ex (80%) and p 
(20%) forms. Glutamate may interact synergistically with the exl-adrenergic 
receptor to stimulate production of the ex-form of the enzyme which would 
then inhibit cAMP formation. This hypothesis could be tested by examing the 
isoforms of PKC that are produced after treatment of the gland with 
glutamate in conjunction with lso and PE. 
The minimum concentration of glutamate required to inhibit 
melatonin production was lmM, approximately 7 times the concentration of 
glutamate found in plasma (Pratt 1976). When compared to doses known to 
be toxic in neuronal cell culture, e.g. 100µM for 5 min (Choi and Rothman 
1990), this dose appears excessively high. However, whole tissue such as that 
used in these experiments possesses uptake systems for glutamate that 
remove excess amino acid from the extracellular space. As demonstrated by 
the significant increase in glutamate content of the pineal gland 2.5 hours 
after administration of exogenous glutamate, the pineal gland is capable of 
such uptake. Interestingly, the amount of glutamate taken up by the gland 
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did not produce overall levels of glutamate that were significantly higher 
than those seen in non-perifused samples (18.08 + 0.94 and 15.58 + 2.86 µg/mg 
protein, perifused and non-perifused tissue respectively). Other studies such 
as those employing whole retina have also reported that high concentrations 
of glutamate (0.3 - 30 mM) are required to evoke a physiological response 
(Perlman et al. 1987; Zeevalk et al. 1989). 
While the mechanism of glutamate's interaction with the Iso and PE 
stimulated production of melatonin is not clear, it is probably not due to 
binding of glutamate with any of the currently characterized glutamate 
receptor subtypes. In agreement with the study in Chapter IV that 
demonstrated an inability of kainate, NMDA and quisqualate (which has a 
relatively high affinity for both the AMP A and metabotropic receptors) to 
inhibit [3H]glutamate binding in the pineal gland, these agonists at 10-4M had 
no effect on the Iso and PE stimulated production of melatonin. Likewise, 
trans-ACPD, a ligand specific for the glutamate metabotropic receptor (Palmer 
et al. 1989) and D,L-APB had no effect. A similar lack of stimulation by 
glutamate agonists was seen in mammalian (kainic acid) and turtle 
photoreceptors (Abrams et al. 1989; Tachibana and Kaneko 1988). Because 
turtle retinal photoreceptors responded to L- and D-aspartate as well as L-
glutamate, Tachibana and Keneko (1988) suggested that glutamate exerted its 
effects on membrane depolarization via the interaction of glutamate with an 
electrogenic uptake carrier. Other characteristics of the photoreceptor 
response to glutamate included increased current fluctuations accompanying 
the glutamate-induced current. Based on this observation, Tachibana and 
Keneko (1988) suggested that an ion channel may be involved in the 
glutamate induced response. Whether similar mechanisms are involved in 
glutamate's inhibition of melatonin production in the pineal gland is not 
known. 
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The observation that glutamate must be administered before Iso and PE 
in order to have an effect (see Figs. 6, 19) suggests an alternative mechanism 
for glutamate's action, i.e. the conversion of glutamate to another compound. 
Intracellular utilization of glutamate is supported by the observation that 
glutamine content in the pineal increased by 27% after glutamate 
administration. Similarly, it was reported that when [3H]glutamate was 
incubated with brain tissue at 30°C for 60 minutes, up to 30% of the radiolabel 
was not associated with glutamate at the end of the incubation period 
(Anderson and Vickroy 1990). It is therefore conceivable that the inhibitory 
effects of glutamate are mediated via its decarboxylation to GABA. While 
GABA is found in only small amounts in the rat pineal (Mata et al. 1976), this 
amino acid is able to inhibit melatonin production in vitro (Rosenstein et al. 
1989). The stimulus for the release of GABA from the pineal is the activation 
of the al adrenergic receptor (Rosenstein, et al. 1989). The conversion of 
glutamate to GABA within the pineal gland would explain the inability of 
glutamate to inhibit melatonin production when stimulated by Iso alone. 
Activation of the cx-adrenergic receptor by PE would be required to release 
GABA from the cells which would then allow it to bind to its membrane 
receptor, although there is no direct evidence to support this hypothysis. This 
explanation is not consistent with the observations of Govitrapong and Ebadi 
(1988) who reported that L-allyl-glycine, a GAD inhibitor, did not inhibit the 
glutamate induced inhibition of SNAT activity. These authors failed, 
however, look at the affects of L-allyl-glycine alone on NE-stimulated SNAT 
activity. 
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The present observation that PE did not potentiate the !so-stimulated 
secretion of melatonin was an unexpected finding. In the rat pineal gland, PE 
has been demonstrated to potentiate the !so-stimulated production of second 
messenger (cAMP) (Sugden et al. 1986; Vanecek et al. 1985) and SNAT activity 
(Alphs and Lovenberg 1984; Klein et al. 1983; Sugden et al. 1984). While 
potentiation of melatonin production by PE has been demonstrated in other 
species such as hamster and ovine (Howell and Morgan 1991; Santana et al. 
1989), it has not been demonstated unequivocally in rat. As reported in both 
the hamster and ovine pineal gland, however, cAMP /SNAT activity and 
melatonin production do not always parallel one another (Howell and 
Morgan 1991; Nilsson and Reiter 1989). This suggests that an increase in 
cAMP levels and SNAT activity may not necessarily be accompanied by an 
increase in melatonin production. It is unlikely that the lack of potentiation 
in the present study was due to a maximal effect on melatonin production 
because the amount of hormone could be further increased with a higher 
dose of Iso (IO-SM). 
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Fig. 1. Spontaneous melatonin release from pineal 
glands cultured in vitro. n = 3 pineal glands. 
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Fig. 2. Spontaneous LDH release from pineal glands 
cultured in vitro. n = 6 pineal glands. 
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Fig. 4. The amount of melatonin secreted by pineal glands 
treated with (-)isoproterenol and L-phenylephrine (10-6M) 
does not differ significantly from the amount of melatonin 
produced by glands pretreated with prazosin (10-6M) and 
administered (-)isoproterenol alone (10-6M). n = 6 pineal 
glands/ group. 
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phenylephrine (10-6M) stimulated secretion of melatonin. 
n = 9 pineal glands/ group. 
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Fig. 8. L-Glutamate (5 X 10-4M) pretreatment of 
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and L-phenylephrine (10-6M) stimulated secretion of 
melatonin. n = 6 pineal glands/ group. 
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Fig. 10. Pretreatment of pineal glands with D-glutamate 
(10-3M), the inactive isomer, does not inhibit the 
(-)isoproterenol and L-phenylephrine (10-6M) stimulated 
secretion of melatonin. n = 6 pineal glands/group. 
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Fig. 11. Pretreatment of pineal glands with 10-3M 
L-glutamate did not inhibited melatonin secretion 
stimulated by 10-6M (-)isoproterenol alone. 10-6M 
Prazosin was added to block the al-adrenergic receptor. 
n = 6 pineal glands/ group. 
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Fig. 12. Pretreatment of pineal glands with L-glutamate 
(lo-3M) does not inhibit the (-)isoproterenol (1o-6M) 
stimulated secretion of melatonin. Prazosin was not 
added in this experiment. n = 6 pineal glands/ group. 
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Fig. 13. Pretreatment of pineal glands 
with NMDA (10-4M) does not inhibit 
the (-)isoproterenol and L-phenylephrine 
(10-6M) stimulated secretion of melatonin. 
n = 6 pineal glands/group. Bar graphs 
represent the sum of melatonin secreted 
after L-glutamate administration (p<0.29 
T-test). 
9 10 
Control 
107 
NMDA 
60 --'"O 
~ 50 ro -co 
............. 
~ 40 ·-s 
............. 
co 30 
~ ---~ ·- 20 ~ 
0 
-1-,j 
ro - 10 Q) 
:E 
0 
0 
• Kainate & 
(-)Iso & L-PE 
O (-)Iso & L-PE 
only 
1 2 3 1/5~ 7 8 9 
Kainate (-)Iso & L-PE 
Time (hour) 
Fig. 14. Pretreatment of pineal glands with kainate 
(10-4 M) does not inhibit the (-)isoproterenol and 
L-phenylephrine (10-6 M) stimulated secretion of 
melatonin. n = 6 pineal glands/ group. 
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Fig. 15. Pretreatment of pineal glands with quisqualate 
(10-4M) does not inhibit the (-)isoproterenol and L-
phenylephrine (10-6M) stimulated secretion of melatonin. 
n = 6 pineal glands/ group. 
109 
60 
0 1 
• ACPD& 
(-)Iso & L-PE 
O (-)Iso & L-PE 
only 
2 3 4 t 5 ~ 7 8 9 10 
ACPD (-)Iso & L-PE 
Time (hour) 
Fig. 16. Pretreatment of pineal glands with trans-ACPD 
(104 M) does not inhibit the (-)isoproterenol and 
L-phenylephrine (10-6 M) stimulated secretion of 
melatonin. n = 3 pineal glands/ group. 
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Fig. 17. Pretreatment of pineal glands with D,L-APB 
(2 X1Q-4M) does not inhibit the (-)isoproterenol and 
L-phenylephrine (10-6M) stimulated secretion of 
melatonin. n = 3 pineal glands/ group. 
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does not inhibit melatonin secretion. n = 3 pineal 
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CHAPTER VI 
GENERAL DISCUSSION 
These studies tested the hypothesis that glutamate modulates 
melatonin production in the pineal gland of the rat. The role of the 
adrenergic system in the production of the pineal gland hormone, melatonin, 
is well known. NE, which is released from sympathetic nerve terminals at 
night, binds to a- and ~-adrenergic receptors to stimulate the production of 
pinealocyte cAMP. This increase in cAMP stimulates the transcription and 
translation of the rate limiting enzyme in the synthesis of melatonin, SNAT. 
Melatonin, which is synthesized from the amino acid tryptophan via 
multienzymatic pathway, is released from the gland into the blood stream. 
The proposal of a modulatory role for glutamate in this process in vivo 
requires that several things be demonstrated including (see Fig. 1): 
1) cell surface receptors for glutamate (Seel in Fig. 1) 
2) an endogenous source of glutamate for these receptors (See _i in Fig. 2) 
3) the ability of glutamate to influence melatonin production via binding to 
these receptors (See 3A, ~ 3C, 3D in Fig. 1 and explanation below) 
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1) Glutamate Binding Sites 
In chapter IV, a postsynaptic binding site for glutamate in the rat pineal 
gland is described. The pharmacological profile of this binding site suggests 
that it does not fit into any of the known categories of glutamate receptor 
described in brain. In further analyzing the nature of this glutamate binding 
site, however, it becomes important to determine if a comparison with 
neuronal glutamate receptors is appropriate. While the pineal gland is 
considered a part of the brain (epithalamus) and is embryologically derived 
from neuroectoderm, pinealocytes differ in many ways from neurons. 
Referred to as paraneurons (Ueck and Wake 1977), pinealocytes, like neurons, 
exhibit action potentials (Reuss 1987) and synthesize and release a known 
neurotransmitter, (serotonin is released in response to a1-adrenergic 
stimulation (Aloyo and Walker 1988). On the other hand, pinealocytes 
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display many non-neuronal features. For example, there is no evidence for 
intrapineal synapses like those seen between neurons. In addition, many 
cytochemical neuronal markers such as neuronal adhesion molecule Ll, 
synaptophysin and neurofilament marker R39 are not present in pinealocytes 
(Schroder et al. 1990; Vollrath and Schroder 1987). Finally, a suggestion that 
the receptors present on the gland may not be exactly like receptors present in 
other parts of the brain comes from a study where it has been demonstrated 
with the use of photoaffinity labeling that the J3-adrenergic receptor present in 
the rat pineal has a lower molecular weight than the J3-adrenergic receptor 
described in other tissue including brain (Dickinson et al. 1986). 
Perhaps it would be more appropriate to compare pinealocytes with 
retinal photoreceptors based on histochemical, morphological and 
phylogenetic evidence. Accordingly, the glutamate binding site present in the 
rat pineal may be more closely related to the glutamate binding site present 
on photoreceptors. Recent characterization of glutamate receptors in turtle 
photoreceptors using electrophysiological techniques indicates that these sites 
are not similar to the glutamate binding sites within the rest of the brain 
(Tachibana and Kaneko 1988). In the photoreceptor of the turtle, the 
glutamate binding site has been characterized as a "functional" uptake site. 
While none of the known glutamate agonists stimulated depolarization in 
photoreceptors, D-aspartate and L-aspartate, substrates of the glutamate 
uptake system were effective (Tachibana and Kaneko 1988). Addition of a 
glutamate uptake inhibitor also reduced the glutamate-induced current. 
Therefore, the possibility that the binding site described in this study is an 
uptake site for glutamate must also be considered. 
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There is no doubt that a glutamate uptake site is present in the pineal 
gland as extracellular glutamate can be accumulated by this organ (chapter V, 
Fig. 20). Whether this site is responsible for this uptake or whether there is 
another, lower affinity uptake site, is unknown. While binding was 
performed in Na2+, and c1- free conditions, it is possible that local tissue 
concentrations of these ions remained high enough to stimulate glutamate 
uptake. It would be important to examine the effects of a specific glutamate 
uptake inhibitor such as L-trans-pyrrolidine-2,4-dicarboxylic acid on the ability 
of glutamate to inhibit the Iso and PE-stimulated production of melatonin. 
Based on the diversity of glutamate binding sites defined pharmacologically, 
e.g. the NMDA, kainate, AMPA, APB, and metabotropic receptors in the CNS, 
and the glutamate binding sites in photoreceptor and pituitary gland, as well 
as those defined with the use of molecular techniques, the possibility that the 
pineal gland of the rat possesses a unique type of glutamate receptor must also 
be considered. 
Assuming that glutamate exerts its effects on pinealocytes via binding 
to either an uptake site or a receptor, the mechanism for glutamate inhibition 
of Iso and PE-stimulated melatonin secretion remains an enigma. It was 
originally hypothesized that glutamate inhibits the a- and ~-adrenergic 
stimulated production of melatonin by inhibiting the a-adrenergic stimulated 
production of inositol phosphates. It had been demonstrated in brain that 
glutamate and quisqualate inhibited incorporation of [3H]inositol into the 
larger phospholipid molecule. If glutamate or quisqualate were administered 
before NE, it was demonstrated that activation of the a-adrenergic receptor 
produced less IP3 (Jope and Li 1989). It had been assumed that the~-
adrenergic stimulated production of melatonin, like the ~-adrenergic 
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stimulated production of cAMP and SNAT activity, would be potentiated by 
activation of the a-adrenergic receptor. It was therefore hypothesized that 
addition of glutamate to pineal glands stimulated with both a- and P-
adrenergic agonists would reduce melatonin secretion to the same extent that 
activation of the a-adrenergic receptor would potentiate P-adrenergic 
stimulated melatonin production. This idea was not borne out by our data 
demonstrating lack of potentiation of melatonin production in glands treated 
with both a and P-adrenergic agonist when compared to glands stimulated 
with a P-adrenergic agonist alone (chapter V Fig. 4). In addition the role of 
inositol phospholipid production in melatonin synthesis has been questioned 
(Sugden et al. 1988; Sugden et al. 1987). Several other mechanisms for 
glutamate inhibition of Iso- and PE-stimulated secretion of melatonin as 
discussed in Chapter V include: A) cell death or toxicity; B) pinealocyte 
depolarization; C) inhibition of cAMP by the a-isoform of PKC; and D) 
conversion of glutamate to GABA (chapter VI Fig. 1). 
2) Endogenous Glutamate 
While glutamate can inhibit the secretion of melatonin in vitro, a 
physiological role for this amino acid in vivo requires that a regular source of 
glutamate be available to the gland. Our immunocytochemical data 
demonstrated that glutamate is not concentrated in nerve terminals in the 
pineal gland when compared to glutamate immunolabeling over other cell 
types in the gland suggesting that the SCG is not a source of "transmitter" 
glutamate. While glutamate may be tonically released and not stored for long 
periods of time, there are, to my knowledge, no studies that have described a 
co-localization or co-release of glutamate and NE. Central neuronal 
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connections do not seem a likely source of glutamate as there is no 
compelling evidence for the presence of such fibers in the pineal gland of the 
rat. The possibility that glutamate is blood borne or found in the CSF may be 
considered as the pineal gland has one of the highest flow rates of blood in 
the body (on a per weight basis) (Goldman and Wurtrnan 1964) and is 
surrounded by CSF. These possibilities, however, both seem unlikely because 
blood and CSF do not have high levels of glutamate (0.15 mM and 0.4 µM 
respectively) (Alfredsson et al. 1988; Pardridge 1979) and 0.5 mM glutamate 
did not inhibit the Iso and PE stimulated production of melatonin in vitro 
(Chapter V, Fig. 8). Another possibility is that the pineal gland itself serves as 
a source of glutamate. It has been demonstrated in turtle photoreceptors that 
glutamate is released upon depolarization of the cell (Copenhagen and Jahr 
1989). NE, however, hyperpolarizes the pinealocyte membrane (Parfitt et al. 
1975; Sakai and Marks 1972). The presence of glutamate binding sites in the 
pineal gland without a definitive glutaminergic input is an obvious problem. 
However, in many other brain regions mismatch between neurotransmitters 
and their receptors have been documented (Herkenham and McLean 1986). 
3) Glutamate Modulation of Melatonin Secretion 
While glutamate administered before Iso and PE inhibits the amount 
of melatonin released by the pineal gland in vitro, the physiological relevance 
of this finding must be addressed in light of what has been called the duration 
hypothysis. It has been suggested that what is physiologicaly important to the 
animal is not an increase or decrease in the amount of melatonin that it is 
exposed to, but the amount of time that the animal is exposed to it. For 
example, the pineal gland of the aged Syrian hamster produces significantly 
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less melatonin than the pineal gland of a younger animal (Reiter et al. 1980). 
In spite of the overall decreased levels of melatonin, exposure of these 
animals to short days will still induce gonadal regression. This indicates that 
it is the duration of the melatonin signal that induces this change and not the 
total amount of melatonin produced. Because the production of melatonin 
in this study was followed for only 4 hours after stimulation by Iso and PE 
(Chapter V, Fig. 6), it could not be discerned whether one hour of glutamate 
pretreatment would shorten the overall duration of the melatonin signal. 
It is interesting to note that the pineal gland has been suggested by 
more than one author to serve as a model for events in the central nervous 
system. In light of the observation made in this study, it is suggested that this 
idea be approached with caution. 
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